Search
Patexia Research
Case number 1:21-cv-01138

Jazz Pharmaceuticals, Inc. et al v. Avadel CNS Pharmaceuticals, LLC > Documents

Date Field Doc. No.Description (Pages)
Oct 4, 2024 595 ORAL ORDER: In light of the court's memorandum order dated September 24, 2024 (D.I. 585) denying Avadel's emergency motion to stay, Jazz's Motion to Strike Avadel's Reply in Support of its Emergency Motion for Stay Pending Appeal (D.I. 560) is DENIED AS MOOT. ORDERED by Judge Gregory B. Williams on 10/4/2024. (lnb) (Entered: 10/04/2024) (0)
Oct 4, 2024 596 ORDER re (505 in 1:21-cv-01594-GBW, 507 in 1:21-cv-01138-GBW, 630 in 1:21-cv-00691-GBW) Joint MOTION to Redact (596 in 1:21-cv-00691-GBW) Transcript,, (Trial Day 2) filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. Signed by Judge Gregory B. Williams on 10/4/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 10/04/2024) (2)
Oct 4, 2024 597 REDACTED VERSION of (580 in 1:21-cv-01138-GBW, 578 in 1:21-cv-01594-GBW, 705 in 1:21-cv-00691-GBW) Letter, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 10/04/2024) (30)
Oct 4, 2024 598 REDACTED VERSION of (581 in 1:21-cv-01138-GBW, 579 in 1:21-cv-01594-GBW, 706 in 1:21-cv-00691-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 10/04/2024) (30)
Oct 4, 2024 599 REDACTED VERSION of (583 in 1:21-cv-01138-GBW, 708 in 1:21-cv-00691-GBW, 581 in 1:21-cv-01594-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 10/04/2024) (5)
Oct 4, 2024 600 REDACTED VERSION of (707 in 1:21-cv-00691-GBW, 582 in 1:21-cv-01138-GBW, 580 in 1:21-cv-01594-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 10/04/2024) (6)
Oct 4, 2024 601 REDACTED VERSION of (709 in 1:21-cv-00691-GBW, 584 in 1:21-cv-01138-GBW, 582 in 1:21-cv-01594-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. AA-CC, # 2 Exs. 33-37)(Tigan, Jeremy) (Entered: 10/04/2024) (0)
Oct 3, 2024 594 STIPULATION TO EXTEND TIME to submit redacted public versions of D.I. Nos. 705-709 (C.A. No. 21-691), D.I. Nos. 580-584 (C.A. No. 21-1138), and D.I. Nos. 578-582 (C.A. No. 21-1594) to October 4, 2024 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 10/03/2024) (2)
Oct 2, 2024 588 ORDER of USCA as to 544 Notice of Appeal (Federal Circuit) filed by Avadel CNS Pharmaceuticals LLC. Decision of USCA: (1) The motions are granted to the limited extent described in this order. (2) These appeals shall be placed on the February 2025 oral argument calendar. (jaa) (Entered: 10/02/2024) (3)
Oct 2, 2024 589 REDACTED VERSION of (690 in 1:21-cv-00691-GBW, 565 in 1:21-cv-01138-GBW, 563 in 1:21-cv-01594-GBW) Letter by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 10/02/2024) (30)
Oct 2, 2024 590 REDACTED VERSION of (691 in 1:21-cv-00691-GBW, 566 in 1:21-cv-01138-GBW, 564 in 1:21-cv-01594-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 10/02/2024) (30)
Oct 2, 2024 591 REDACTED VERSION of (687 in 1:21-cv-00691-GBW, 562 in 1:21-cv-01138-GBW, 560 in 1:21-cv-01594-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 10/02/2024) (9)
Oct 2, 2024 592 REDACTED VERSION of (561 in 1:21-cv-01594-GBW, 688 in 1:21-cv-00691-GBW, 563 in 1:21-cv-01138-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-7)(Tigan, Jeremy) (Entered: 10/02/2024) (0)
Oct 2, 2024 593 REDACTED VERSION of (564 in 1:21-cv-01138-GBW, 562 in 1:21-cv-01594-GBW, 689 in 1:21-cv-00691-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-32)(Tigan, Jeremy) (Entered: 10/02/2024) (0)
Sep 30, 2024 587 STIPULATION TO EXTEND TIME for the parties to file public versions of their Letters regarding Ongoing Royalty and Supporting Documents (C.A. 21-691, D.I. No. 687-692, 705-709; C.A. 21-1138, D.I. No. 562-567, 580-584; and C.A. 21-1594, D.I. No. 560-565, 578-582) to October 3, 2024 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/30/2024) (2)
Sep 27, 2024 586 Amended NOTICE of of Appeal by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC re (710 in 1:21-cv-00691-GBW, 585 in 1:21-cv-01138-GBW, 583 in 1:21-cv-01594-GBW) Memorandum and Order, (542 in 1:21-cv-01138-GBW, 540 in 1:21-cv-01594-GBW, 665 in 1:21-cv-00691-GBW) Memorandum Opinion, (667 in 1:21-cv-00691-GBW) Notice of Appeal (Federal Circuit), (666 in 1:21-cv-00691-GBW, 541 in 1:21-cv-01594-GBW, 543 in 1:21-cv-01138-GBW) Order, (542 in 1:21-cv-01594-GBW) Notice of Appeal (Federal Circuit), (544 in 1:21-cv-01138-GBW) Notice of Appeal (Federal Circuit) (Silver, Daniel) (Entered: 09/27/2024) (3)
Sep 24, 2024 585 MEMORANDUM ORDER re (547 in 1:21-cv-01138-GBW, 670 in 1:21-cv-00691-GBW, 545 in 1:21-cv-01594-GBW) Emergency MOTION to Stay Pending Appeal filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC Signed by Judge Gregory B. Williams on 9/24/2024.This order has been emailed to local counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) Modified on 9/24/2024 (lnb). Modified and Unsealed on 10/10/2024 (lnb). (Main Document 585 replaced on 10/10/2024) (lnb). (Entered: 09/24/2024) (7)
Sep 23, 2024 579 ORDER re (578 in 1:21-cv-01138-GBW, 576 in 1:21-cv-01594-GBW, 703 in 1:21-cv-00691-GBW) STIPULATION TO EXTEND TIME for the parties to file public versions of D.I. Nos. 687-692 (C.A. No. 21-691); D.I. Nos.562-567 (C.A. No. 21-1138); D.I. Nos. 560-565 (C.A. No. 21-1594) to September 30, 2024 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. Signed by Judge Gregory B. Williams on 9/23/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 09/23/2024) (2)
Sep 23, 2024 580 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Responsive Ongoing Royalty Letter - re (687 in 1:21-cv-00691-GBW, 562 in 1:21-cv-01138-GBW, 560 in 1:21-cv-01594-GBW) Letter,. (Attachments: # 1 Exhibits 1-5, # 2 Certificate of Service)(Silver, Daniel) (Entered: 09/23/2024) (0)
Sep 23, 2024 581 [SEALED] DECLARATION re (580 in 1:21-cv-01138-GBW, 578 in 1:21-cv-01594-GBW, 705 in 1:21-cv-00691-GBW) Letter, Declaration of Mohan Rao, Ph.D. by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/23/2024) (0)
Sep 23, 2024 582 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Ongoing Royalty - re (691 in 1:21-cv-00691-GBW, 566 in 1:21-cv-01138-GBW, 564 in 1:21-cv-01594-GBW) Declaration, (690 in 1:21-cv-00691-GBW, 565 in 1:21-cv-01138-GBW, 563 in 1:21-cv-01594-GBW) Letter. (Attachments: # 1 Proposed Order)(Tigan, Jeremy) (Entered: 09/23/2024) (0)
Sep 23, 2024 583 [SEALED] DECLARATION re (580 in 1:21-cv-01138-GBW, 578 in 1:21-cv-01594-GBW, 705 in 1:21-cv-00691-GBW) Letter, Declaration of Paul Weil by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/23/2024) (0)
Sep 23, 2024 584 [SEALED] DECLARATION re (707 in 1:21-cv-00691-GBW, 582 in 1:21-cv-01138-GBW, 580 in 1:21-cv-01594-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. AA-CC, # 2 Exs. 33-37)(Tigan, Jeremy) (Entered: 09/23/2024) (0)
Sep 20, 2024 578 STIPULATION TO EXTEND TIME for the parties to file public versions of D.I. Nos. 687-692 (C.A. No. 21-691); D.I. Nos.562-567 (C.A. No. 21-1138); D.I. Nos. 560-565 (C.A. No. 21-1594) to September 30, 2024 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 09/20/2024) (2)
Sep 19, 2024 574 REDACTED VERSION of (683 in 1:21-cv-00691-GBW) Reply Brief, (558 in 1:21-cv-01138-GBW) Reply Brief, (556 in 1:21-cv-01594-GBW) Reply Brief by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 09/19/2024) (25)
Sep 19, 2024 575 REDACTED VERSION of (559 in 1:21-cv-01138-GBW, 684 in 1:21-cv-00691-GBW, 557 in 1:21-cv-01594-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 09/19/2024) (3)
Sep 19, 2024 576 REDACTED VERSION of (559 in 1:21-cv-01594-GBW) Response to Motion, (686 in 1:21-cv-00691-GBW) Response to Motion, (561 in 1:21-cv-01138-GBW) Response to Motion, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 09/19/2024) (8)
Sep 19, 2024 577 REDACTED VERSION of (560 in 1:21-cv-01138-GBW, 558 in 1:21-cv-01594-GBW, 685 in 1:21-cv-00691-GBW) MOTION --Plaintiffs' Motion to Strike Defendant's Reply in Support of its Emergency Motion for Stay Pending Appeal, Or in the Alternative, Plaintiffs' Sur-Reply Thereto-- re (683 in 1:21-cv-00691-GBW) Reply Brief, (558 in 1:21-cv-011 by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 09/19/2024) (10)
Sep 17, 2024 568 REDACTED VERSION of (547 in 1:21-cv-01138-GBW, 670 in 1:21-cv-00691-GBW, 545 in 1:21-cv-01594-GBW) Emergency MOTION to Stay Pending Appeal by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 09/17/2024) (8)
Sep 17, 2024 569 REDACTED VERSION of (548 in 1:21-cv-01138-GBW) Opening Brief in Support, (546 in 1:21-cv-01594-GBW) Opening Brief in Support, (671 in 1:21-cv-00691-GBW) Opening Brief in Support, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 09/17/2024) (30)
Sep 17, 2024 570 REDACTED VERSION of (672 in 1:21-cv-00691-GBW, 549 in 1:21-cv-01138-GBW, 547 in 1:21-cv-01594-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 09/17/2024) (6)
Sep 17, 2024 571 REDACTED VERSION of (554 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (679 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (552 in 1:21-cv-01594-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/17/2024) (27)
Sep 17, 2024 572 REDACTED VERSION of (680 in 1:21-cv-00691-GBW, 553 in 1:21-cv-01594-GBW, 555 in 1:21-cv-01138-GBW) Exhibit to a Document, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/17/2024) (30)
Sep 17, 2024 573 REDACTED VERSION of (556 in 1:21-cv-01138-GBW, 554 in 1:21-cv-01594-GBW, 681 in 1:21-cv-00691-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/17/2024) (6)
Sep 16, 2024 561 [SEALED] RESPONSE to Motion re 560 MOTION --Plaintiffs' Motion to Strike Defendant's Reply in Support of its Emergency Motion for Stay Pending Appeal, Or in the Alternative, Plaintiffs' Sur-Reply Thereto-- re (683 in 1:21-cv-00691-GBW) Reply Brief, (558 in 1:21-cv-011 filed by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 09/16/2024) (0)
Sep 16, 2024 562 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Jazz's Letter Brief in Support of Ongoing Royalty - re (543 in 1:21-cv-01594-GBW, 545 in 1:21-cv-01138-GBW, 668 in 1:21-cv-00691-GBW) Order, (540 in 1:21-cv-01594-GBW, 542 in 1:21-cv-01138-GBW, 665 in 1:21-cv-00691-GBW) Memorandum Opinion. (Tigan, Jeremy) (Entered: 09/16/2024) (0)
Sep 16, 2024 563 [SEALED] DECLARATION re (687 in 1:21-cv-00691-GBW, 562 in 1:21-cv-01138-GBW, 560 in 1:21-cv-01594-GBW) Letter, -- Declaration of Steven R. Little, Ph.D. -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-7)(Tigan, Jeremy) (Entered: 09/16/2024) (0)
Sep 16, 2024 564 [SEALED] DECLARATION re (687 in 1:21-cv-00691-GBW, 562 in 1:21-cv-01138-GBW, 560 in 1:21-cv-01594-GBW) Letter, -- Declaration of Mark Rainey, Ph.D. -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-32)(Tigan, Jeremy) (Entered: 09/16/2024) (0)
Sep 16, 2024 565 [SEALED] Letter to the Honorable Gregory B. Williams from Daniel M. Silver regarding Ongoing Royalty. (Attachments: # 1 Exhibits 1-2, # 2 Proposed Order, # 3 Certificate of Service)(Silver, Daniel) (Entered: 09/16/2024) (0)
Sep 16, 2024 566 [SEALED] DECLARATION re (690 in 1:21-cv-00691-GBW, 565 in 1:21-cv-01138-GBW, 563 in 1:21-cv-01594-GBW) Letter Declaration of Mohan Rao, Ph.D. by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/16/2024) (0)
Sep 16, 2024 567 [SEALED] NOTICE of Lodging by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. re (564 in 1:21-cv-01138-GBW, 562 in 1:21-cv-01594-GBW, 689 in 1:21-cv-00691-GBW) Declaration, (Tigan, Jeremy) (Entered: 09/16/2024) (0)
Sep 13, 2024 560 [SEALED] MOTION --Plaintiffs' Motion to Strike Defendant's Reply in Support of its Emergency Motion for Stay Pending Appeal, Or in the Alternative, Plaintiffs' Sur-Reply Thereto-- re (683 in 1:21-cv-00691-GBW) Reply Brief, (558 in 1:21-cv-01138-GBW) Reply Brief, (556 in 1:21-cv-01594-GBW) Reply Brief - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/13/2024) (0)
Sep 12, 2024 558 [SEALED] REPLY BRIEF re 547 Emergency MOTION to Stay Pending Appeal filed by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Exhibit D, # 2 Certificate of Service)(Silver, Daniel) (Entered: 09/12/2024) (0)
Sep 12, 2024 559 [SEALED] DECLARATION re (683 in 1:21-cv-00691-GBW) Reply Brief, (558 in 1:21-cv-01138-GBW) Reply Brief, (556 in 1:21-cv-01594-GBW) Reply Brief Declaration of Jennifer Gudeman by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/12/2024) (0)
Sep 10, 2024 551 Letter to The Honorable Gregory B. Williams from Daniel M. Silver. regarding Avadels emergency motion to stay the Courts injunction order pending appeal. (Silver, Daniel) (Entered: 09/10/2024) (1)
Sep 10, 2024 552 ORDER of USCA as to 544 Notice of Appeal (Federal Circuit) filed by Avadel CNS Pharmaceuticals LLC. Decision of USCA: (1) The above-captioned appeals are consolidated, and thus one set of briefing should be filed for the appeals. The revised official caption is reflected in this order. (2) The scheduling motions are granted to the extent that: (a) Jazz Pharmaceuticals, LLC et al.s response to the stay motions is due no later than September 13,2024, and Avadels reply is due no later than September 16, 2024. (b) Avadels opening brief is due no later than September 20, 3024; Jazzs response brief is due no later than November 7, 2024; Avadels reply brief is due no later than November 18, 2024; and the joint appendix is due no later than November 19, 2024. The parties should not anticipate extensions of time, and oral argument will be addressed separately. (jaa) (Entered: 09/10/2024) (3)
Sep 10, 2024 553 CORRECTED ORDER of USCA as to 544 Notice of Appeal (Federal Circuit) filed by Avadel CNS Pharmaceuticals LLC. Decision of USCA: (1) The above-captioned appeals are consolidated, and thus one set of briefing should be filed for the appeals. The revised official caption is reflected in this order. (2) The scheduling motions are granted to the extent that: (a) Jazz Pharmaceuticals, LLC et al.'s response to the stay motions is due no later than September 13, 2024, and Avadel's reply is due no later than September 16, 2024. (b) Avadel's opening brief is due no later than September 20, 2024; Jazz's response brief is due no later than November 7, 2024; Avadel's reply brief is due no later than November 18, 2024; and the joint appendix is due no later than November 19, 2024. The parties should not anticipate extensions of time, and oral argument will be addressed separately. (jaa) (Entered: 09/10/2024) (3)
Sep 10, 2024 554 [SEALED] ANSWERING BRIEF in Opposition re 547 Emergency MOTION to Stay Pending Appeal filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 9/17/2024. (Tigan, Jeremy) (Entered: 09/10/2024) (0)
Sep 10, 2024 555 [SEALED] EXHIBIT re (554 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (679 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (552 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (Exhibits 1-15) by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/10/2024) (0)
Sep 10, 2024 556 [SEALED] DECLARATION re (554 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (679 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (552 in 1:21-cv-01594-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/10/2024) (0)
Sep 10, 2024 557 STIPULATION TO EXTEND TIME for Avadel to Submit Redacted Public Versions of its Emergency Motion to Stay Pending Appeal and Supporting Documents (C.A. 21-691, D.I. No. 670-672; C.A. 21-1138, D.I. No. 547-549; and C.A. 21-1594, D.I. No. 545-547) to September 17, 2024 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 09/10/2024) (2)
Sep 4, 2024 550 Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding proposed public version of the Memorandum Opinion (C.A. No. 21-691, D.I. 665; C.A. No. 21-1138, D.I. 542; and C.A. No. 21-1594, D.I. 540). - re (543 in 1:21-cv-01594-GBW, 545 in 1:21-cv-01138-GBW, 668 in 1:21-cv-00691-GBW) Order,. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 09/04/2024) (0)
Sep 3, 2024 547 [SEALED] Emergency MOTION to Stay Pending Appeal - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Rule 7.1.1 Certification, # 2 Proposed Order, # 3 Certificate of Service)(Silver, Daniel) (Entered: 09/03/2024) (0)
Sep 3, 2024 548 [SEALED] OPENING BRIEF in Support re 547 Emergency MOTION to Stay Pending Appeal filed by Avadel CNS Pharmaceuticals LLC.Answering Brief/Response due date per Local Rules is 9/17/2024. (Attachments: # 1 Exhibits A-C, # 2 Certificate of Service)(Silver, Daniel) (Entered: 09/03/2024) (0)
Sep 3, 2024 549 [SEALED] DECLARATION re (547 in 1:21-cv-01138-GBW, 670 in 1:21-cv-00691-GBW, 545 in 1:21-cv-01594-GBW) Emergency MOTION to Stay Pending Appeal Declaration of Jennifer Gudeman by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/03/2024) (0)
Aug 30, 2024 546 NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 544 Notice of Appeal (Federal Circuit) filed by Avadel CNS Pharmaceuticals LLC. USCA Case Number 2024-2277 (jaa) (Entered: 08/30/2024) (4)
Aug 28, 2024 544 Notice of Appeal* (1)
Aug 28, 2024 545 ORAL ORDER: The parties are to meet and confer and jointly get back to the Court in writing, on or before September 4, 2024, with any proposed redactions to the Memorandum Opinion. Otherwise, the Memorandum Opinion will be unsealed in its entirety. ORDERED by Judge Gregory B. Williams on 8/28/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 08/28/2024) (0)
Aug 27, 2024 542 [SEALED] MEMORANDUM OPINION. Signed by Judge Gregory B. Williams on 8/27/2024.This order is available for pickup at Clerks Office by local counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 08/27/2024) (0)
Aug 27, 2024 543 ORDER re (540 in 1:21-cv-01594-GBW, 542 in 1:21-cv-01138-GBW, 665 in 1:21-cv-00691-GBW) Memorandum Opinion. Signed by Judge Gregory B. Williams on 8/27/2024.This order is available for pickup at Clerks Office by local counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Main Document 666 replaced on 8/28/2024) (lnb). (Main Document 666 replaced on 8/28/2024) (lnb). Modified and UNSEALED by agreement between and at the request of counsel on 8/28/2024 (lnb). (Entered: 08/27/2024) (3)
Aug 21, 2024 541 NOTICE requesting Clerk to remove Eric P. Berger as co-counsel.. (Joyce, Alexandra) (Entered: 08/21/2024) (2)
Aug 13, 2024 539 REDACTED VERSION of (534 in 1:21-cv-01594-GBW, 536 in 1:21-cv-01138-GBW, 659 in 1:21-cv-00691-GBW) Letter, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Exhibit A)(Joyce, Alexandra) (Entered: 08/13/2024) (0)
Aug 13, 2024 540 REDACTED VERSION of (535 in 1:21-cv-01594-GBW, 660 in 1:21-cv-00691-GBW, 537 in 1:21-cv-01138-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1)(Tigan, Jeremy) (Entered: 08/13/2024) (0)
Aug 6, 2024 538 STIPULATION TO EXTEND TIME to file public redacted versions of (1) Avadel's July 30, 2024 letter and (2) Jazz's July 31, 2024 letter to (1) August 13, 2024 and (2) August 14, 2024 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 08/06/2024) (2)
Jul 31, 2024 537 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding response to Avadel's July 30, 2024 letter - re (534 in 1:21-cv-01594-GBW, 536 in 1:21-cv-01138-GBW, 659 in 1:21-cv-00691-GBW) Letter,. (Attachments: # 1 Ex. 1)(Tigan, Jeremy) (Entered: 07/31/2024) (0)
Jul 30, 2024 536 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Notice of sworn testimony from Jazz's corporate witness relevant to Jazz's motion for a permanent injunction. (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Silver, Daniel) (Entered: 07/30/2024) (0)
Jul 29, 2024 535 NOTICE requesting Clerk to remove Laryssa Bedley as co-counsel.. (Joyce, Alexandra) (Entered: 07/29/2024) (2)
Jul 23, 2024 534 STATEMENT Defendant's Response to Plaintiff's Notice of Subsequent Authority by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 07/23/2024) (3)
Jul 17, 2024 533 NOTICE of Subsequent Authority in Support of Plaintiff's Motion for a Permanent Injunction and for an Ongoing Royalty by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 07/17/2024) (0)
Jun 27, 2024 532 REDACTED VERSION of (525 in 1:21-cv-01594-GBW, 527 in 1:21-cv-01138-GBW, 650 in 1:21-cv-00691-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A)(Clark, Cameron) (Entered: 06/27/2024) (0)
Jun 26, 2024 531 STIPULATION TO EXTEND TIME for Jazz to submit a redacted public version of its June 13, 2024 letter (C.A. 21-691, D.I. No. 650; C.A. 21-1138, D.I. No. 527; and C.A. 21-1594, D.I. No. 525) to June 27, 2024 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 06/26/2024) (2)
Jun 21, 2024 530 STIPULATION TO EXTEND TIME for Jazz to submit a redacted public version of its June 13, 2024 letter (C.A. 21-691, D.I. No. 650; C.A. 21-1138, D.I. No. 527; and C.A. 21-1594, D.I. No. 525) to June 26, 2024 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 06/21/2024) (2)
Jun 18, 2024 528 REDACTED VERSION of (522 in 1:21-cv-01138-GBW, 520 in 1:21-cv-01594-GBW, 645 in 1:21-cv-00691-GBW) Unopposed MOTION to Seal Document: (423 in 1:21-cv-01594-GBW, 425 in 1:21-cv-01138-GBW, 539 in 1:21-cv-00691-GBW) Memorandum Opinion, - -Plaintiffs' Unopposed Motion to Seal and Redact Memorandum Opinion- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-B)(Clark, Cameron) (Entered: 06/18/2024) (0)
Jun 18, 2024 529 REDACTED VERSION of (523 in 1:21-cv-01138-GBW, 521 in 1:21-cv-01594-GBW, 646 in 1:21-cv-00691-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 06/18/2024) (7)
Jun 13, 2024 525 ORDER re (522 in 1:21-cv-01138-GBW, 520 in 1:21-cv-01594-GBW, 645 in 1:21-cv-00691-GBW) Unopposed MOTION to Seal Document: (423 in 1:21-cv-01594-GBW, 425 in 1:21-cv-01138-GBW, 539 in 1:21-cv-00691-GBW) Memorandum Opinion filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/12/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 06/13/2024) (2)
Jun 13, 2024 526 REDACTED PUBLIC VERSION of 425 Memorandum Opinion. (lnb) (Entered: 06/13/2024) (30)
Jun 13, 2024 527 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Jazz's Response to Avadel's June 12, 2024 Letter - re (522 in 1:21-cv-01594-GBW, 647 in 1:21-cv-00691-GBW, 524 in 1:21-cv-01138-GBW) Letter. (Attachments: # 1 Exhibit A)(Tigan, Jeremy) (Entered: 06/13/2024) (0)
Jun 12, 2024 524 Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding issues raised by Jazz at the June 4th hearing on Jazz's Motion for a Permanent Injunction. (Silver, Daniel) (Entered: 06/12/2024) (2)
Jun 11, 2024 522 [SEALED] Unopposed MOTION to Seal Document: (423 in 1:21-cv-01594-GBW, 425 in 1:21-cv-01138-GBW, 539 in 1:21-cv-00691-GBW) Memorandum Opinion, - -Plaintiffs' Unopposed Motion to Seal and Redact Memorandum Opinion- - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order)(Tigan, Jeremy) (Entered: 06/11/2024) (0)
Jun 11, 2024 523 [SEALED] DECLARATION re (522 in 1:21-cv-01138-GBW, 520 in 1:21-cv-01594-GBW, 645 in 1:21-cv-00691-GBW) Unopposed MOTION to Seal Document: (423 in 1:21-cv-01594-GBW, 425 in 1:21-cv-01138-GBW, 539 in 1:21-cv-00691-GBW) Memorandum Opinion, - -Plaintiffs' Unopposed Motion to Seal and Redact Memorandum Opinion- -Declaration of P.J. Honerkamp- - by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 06/11/2024) (0)
Jun 6, 2024 520 SO ORDERED, re (519 in 1:21-cv-01138-GBW, 107 in 1:22-cv-00487-GBW, 642 in 1:21-cv-00691-GBW, 517 in 1:21-cv-01594-GBW) STIPULATION TO EXTEND TIME to file proposed redacted versions of any opinion the Court has issued under seal to June 11, 2024 filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. Signed by Judge Gregory B. Williams on 6/6/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00487-GBW(lnb) (Entered: 06/06/2024) (0)
Jun 6, 2024 521 REDACTED VERSION of (505 in 1:21-cv-01594-GBW, 507 in 1:21-cv-01138-GBW, 630 in 1:21-cv-00691-GBW) Joint MOTION to Redact (596 in 1:21-cv-00691-GBW) Transcript,, (Trial Day 2) by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 06/06/2024) (30)
Jun 5, 2024 519 STIPULATION TO EXTEND TIME to file proposed redacted versions of any opinion the Court has issued under seal to June 11, 2024 - filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. (Joyce, Alexandra) (Entered: 06/05/2024) (3)
Jun 4, 2024 518 SO ORDERED, re (515 in 1:21-cv-01594-GBW, 517 in 1:21-cv-01138-GBW, 640 in 1:21-cv-00691-GBW) MOTION for Exemption of Person from the District of Delaware's May 17, 2024 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/4/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) Modified on 6/4/2024 (lnb). Modified on 6/4/2024 (lnb). (Entered: 06/04/2024) (3)
Jun 3, 2024 513 SO ORDERED, re (631 in 1:21-cv-00691-GBW, 508 in 1:21-cv-01138-GBW, 506 in 1:21-cv-01594-GBW) MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/3/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 06/03/2024) (3)
Jun 3, 2024 514 SO ORDERED, re (633 in 1:21-cv-00691-GBW, 510 in 1:21-cv-01138-GBW, 508 in 1:21-cv-01594-GBW) MOTION for Exemption of Person from the District of Delaware's May 17, 2024 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 6/3/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 06/03/2024) (3)
Jun 3, 2024 515 ORDER re (635 in 1:21-cv-00691-GBW, 512 in 1:21-cv-01138-GBW, 510 in 1:21-cv-01594-GBW) MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. Signed by Judge Gregory B. Williams on 6/3/2024. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(lnb) (Entered: 06/03/2024) (2)
Jun 3, 2024 516 NOTICE of Supplemental Authority by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC (Attachments: # 1 Exhibit A)(Silver, Daniel) (Entered: 06/03/2024) (0)
Jun 3, 2024 517 MOTION for Exemption of Person from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 06/03/2024) (3)
May 31, 2024 508 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 05/31/2024) (3)
May 31, 2024 509 Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Avadel's Notice of Intent to Rely on Evidence at June 4, 2024 Hearing - re CORRECTING ENTRY:, (506 in 1:21-cv-01138-GBW, 504 in 1:21-cv-01594-GBW, 629 in 1:21-cv-00691-GBW) Letter,. (Attachments: # 1 Exhibits 1-2)(Tigan, Jeremy) (Entered: 05/31/2024) (0)
May 31, 2024 510 MOTION for Exemption of Person from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 05/31/2024) (3)
May 31, 2024 511 NOTICE requesting Clerk to remove Audra Sawyer as co-counsel.. (Joyce, Alexandra) (Entered: 05/31/2024) (2)
May 31, 2024 512 MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Proposed Order)(Joyce, Alexandra) (Entered: 05/31/2024) (0)
May 30, 2024 507 [SEALED] Joint MOTION to Redact (596 in 1:21-cv-00691-GBW) Transcript,, (Trial Day 2) - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Proposed Order, # 2 Exhibit A, # 3 Exhibit B, # 4 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024) (0)
May 29, 2024 506 Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Notice of Intent to Rely on Evidence at June 4, 2024 Hearing. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Silver, Daniel) (Attachment 2 replaced on 5/30/2024) (lnb). (Entered: 05/29/2024) (0)
May 28, 2024 504 REDACTED VERSION of (488 in 1:21-cv-01594-GBW) Reply Brief, (490 in 1:21-cv-01138-GBW) Reply Brief, (610 in 1:21-cv-00691-GBW) Reply Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 20-35)(Tigan, Jeremy) (Entered: 05/28/2024) (0)
May 28, 2024 505 REDACTED VERSION of (489 in 1:21-cv-01594-GBW, 491 in 1:21-cv-01138-GBW, 611 in 1:21-cv-00691-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-K, # 2 Exhibits L-N)(Tigan, Jeremy) (Entered: 05/28/2024) (0)
May 23, 2024 503 ORAL ORDER: IT IS HEREBY ORDERED that, by no later than fourteen (14) days from the date of this Order, the parties shall file a proposed redacted version of any opinions the Court has issued under seal, along with a motion supported by a declaration that contains a clear, factually detailed explanation as to why disclosure of any proposed redacted material would "work a clearly defined and serious injury to the party seeking closure." See In re Avandia Mktg., Sales Practices & Prods. Liab. Litig., 924 F.3d 662, 672 (3d Cr. 2019) (internal quotations omitted). If the parties do not file a proposed redacted version and corresponding motion by the deadline, or if the court determines the motion lacks a meritorious basis, the opinion[s] will be unsealed in whole or in part. Ordered by Judge Gregory B. Williams on 5/22/2024. (lnb) (Entered: 05/23/2024) (0)
May 22, 2024 494 NOTICE of Intent to Request Redaction by Jeremy A. Tigan re (596 in 1:21-cv-00691-GBW) Transcript,, (Tigan, Jeremy) (Entered: 05/22/2024) (5)
May 22, 2024 495 STIPULATION TO EXTEND TIME to submit redactions to the Transcript of the Jury Trial held on February 27, 2024 (Sealed, Day 2) to May 30, 2024 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/22/2024) (2)
May 22, 2024 496 NOTICE of Intent to Request Redaction by Daniel M. Silver re (596 in 1:21-cv-00691-GBW) Transcript,, (Silver, Daniel) (Entered: 05/22/2024) (3)
May 22, 2024 497 REDACTED VERSION of (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/22/2024) (30)
May 22, 2024 498 REDACTED VERSION of (602 in 1:21-cv-00691-GBW, 480 in 1:21-cv-01594-GBW, 482 in 1:21-cv-01138-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/22/2024) (8)
May 22, 2024 499 REDACTED VERSION of (481 in 1:21-cv-01594-GBW, 603 in 1:21-cv-00691-GBW, 483 in 1:21-cv-01138-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/22/2024) (7)
May 22, 2024 500 REDACTED VERSION of (604 in 1:21-cv-00691-GBW, 484 in 1:21-cv-01138-GBW, 482 in 1:21-cv-01594-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/22/2024) (5)
May 22, 2024 501 REDACTED VERSION of (485 in 1:21-cv-01138-GBW, 605 in 1:21-cv-00691-GBW, 483 in 1:21-cv-01594-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/22/2024) (30)
May 22, 2024 502 REDACTED VERSION of (486 in 1:21-cv-01138-GBW, 606 in 1:21-cv-00691-GBW, 484 in 1:21-cv-01594-GBW) Declaration, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/22/2024) (9)
May 21, 2024 493 STIPULATION TO EXTEND TIME to file public redacted versions of - see stip for details - to May 22, 2024 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/21/2024) (2)
May 20, 2024 490 [SEALED] REPLY BRIEF re 472 MOTION for Permanent Injunction and for an Ongoing Royalty filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 20-35)(Tigan, Jeremy) (Entered: 05/20/2024) (0)
May 20, 2024 491 [SEALED] DECLARATION re (488 in 1:21-cv-01594-GBW) Reply Brief, (490 in 1:21-cv-01138-GBW) Reply Brief, (610 in 1:21-cv-00691-GBW) Reply Brief -- Declaration of Richard K. Bogan -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 05/20/2024) (0)
May 20, 2024 492 DECLARATION re (488 in 1:21-cv-01594-GBW) Reply Brief, (490 in 1:21-cv-01138-GBW) Reply Brief, (610 in 1:21-cv-00691-GBW) Reply Brief -- Declaration of Meir H. Kryger, MD, FRCPC -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 05/20/2024) (30)
May 13, 2024 481 [SEALED] ANSWERING BRIEF in Opposition re 472 MOTION for Permanent Injunction and for an Ongoing Royalty filed by Avadel CNS Pharmaceuticals LLC.Reply Brief due date per Local Rules is 5/20/2024. (Attachments: # 1 Exhibits 1-9, # 2 Certificate of Service)(Silver, Daniel) (Entered: 05/13/2024) (0)
May 13, 2024 482 [SEALED] DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Patient No. 1 by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 05/13/2024) (0)
May 13, 2024 483 [SEALED] DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Patient No. 2 by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 05/13/2024) (0)
May 13, 2024 484 [SEALED] DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Patient No. 3 by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 05/13/2024) (0)
May 13, 2024 485 [SEALED] DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Mohan Rao, Ph.D. by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 05/13/2024) (0)
May 13, 2024 486 [SEALED] DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Gregory J. Divis by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 05/13/2024) (0)
May 13, 2024 487 DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Dr. Thomas Stern by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/13/2024) (30)
May 13, 2024 488 DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Maggie Lavender by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/13/2024) (22)
May 13, 2024 489 DECLARATION re (481 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (479 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (601 in 1:21-cv-00691-GBW) Answering Brief in Opposition, Declaration of Dr. Akinyemi Ajayi by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 05/13/2024) (9)
May 1, 2024 480 NOTICE of Intent to Request Redaction by Alexandra M. Joyce re (596 in 1:21-cv-00691-GBW) Transcript,, (Joyce, Alexandra) (Entered: 05/01/2024) (2)
Apr 22, 2024 476 REDACTED VERSION of (470 in 1:21-cv-01594-GBW, 586 in 1:21-cv-00691-GBW, 472 in 1:21-cv-01138-GBW) MOTION for Permanent Injunction and for an Ongoing Royalty by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 04/22/2024) (12)
Apr 22, 2024 477 REDACTED VERSION of (471 in 1:21-cv-01594-GBW) Opening Brief in Support, (473 in 1:21-cv-01138-GBW) Opening Brief in Support, (587 in 1:21-cv-00691-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-6, # 2 Exs. 7-15, # 3 Exs. 16-19)(Tigan, Jeremy) (Main Document 477 replaced on 5/22/2024) (ntl). (Entered: 04/22/2024) (0)
Apr 22, 2024 478 REDACTED VERSION of (474 in 1:21-cv-01138-GBW, 588 in 1:21-cv-00691-GBW, 472 in 1:21-cv-01594-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. A-P)(Tigan, Jeremy) (Entered: 04/22/2024) (0)
Apr 22, 2024 479 REDACTED VERSION of (473 in 1:21-cv-01594-GBW, 589 in 1:21-cv-00691-GBW, 475 in 1:21-cv-01138-GBW) Declaration, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 04/22/2024) (5)
Apr 12, 2024 472 [SEALED] MOTION for Permanent Injunction and for an Ongoing Royalty - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 04/12/2024) (0)
Apr 12, 2024 473 [SEALED] OPENING BRIEF in Support re 472 MOTION for Permanent Injunction and for an Ongoing Royalty filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 4/26/2024. (Attachments: # 1 Exhibits 1-6, # 2 Exhibits 7-15, # 3 Exhibits 16-19)(Tigan, Jeremy) (Main Document 473 replaced on 5/22/2024) (ntl). (Entered: 04/12/2024) (0)
Apr 12, 2024 474 [SEALED] DECLARATION re (473 in 1:21-cv-01138-GBW) Opening Brief in Support, (471 in 1:21-cv-01594-GBW) Opening Brief in Support, (587 in 1:21-cv-00691-GBW) Opening Brief in Support, -- Declaration of P.J. Honerkamp -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-P)(Tigan, Jeremy) (Entered: 04/12/2024) (0)
Apr 12, 2024 475 [SEALED] DECLARATION re (473 in 1:21-cv-01138-GBW) Opening Brief in Support, (471 in 1:21-cv-01594-GBW) Opening Brief in Support, (587 in 1:21-cv-00691-GBW) Opening Brief in Support, -- Declaration of Mark Rainey, Ph.D. -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 04/12/2024) (0)
Mar 19, 2024 471 SUPPLEMENTAL SCHEDULING ORDER and Briefing Schedule: A Hearing is set for 6/4/2024 at 09:00 AM in Courtroom 6B before Judge Gregory B. Williams (1.5 hours per side). Signed by Judge Gregory B. Williams on 3/19/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 03/19/2024) (3)
Mar 13, 2024 469 SO ORDERED, re (466 in 1:21-cv-01594-GBW, 582 in 1:21-cv-00691-GBW, 468 in 1:21-cv-01138-GBW) STIPULATION TO EXTEND TIME to submit Judgment on the Verdict and Post-Trial Status Report to March 15, 2024 filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. Signed by Judge Gregory B. Williams on 3/13/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 03/13/2024) (2)
Mar 13, 2024 470 Joint STATUS REPORT (Post-Trial) by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Tigan, Jeremy) (Entered: 03/13/2024) (0)
Mar 12, 2024 468 STIPULATION TO EXTEND TIME to submit Judgment on the Verdict and Post-Trial Status Report to March 13, 2024 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 03/12/2024) (2)
Mar 5, 2024 464 [SEALED] JURY VERDICT. (ntl) (Entered: 03/05/2024) (0)
Mar 5, 2024 465 REDACTED PUBLIC VERSION of 464 Jury Verdict. (ntl) (Entered: 03/05/2024) (12)
Mar 5, 2024 466 [SEALED] Jury Notes. (ntl) (Entered: 03/05/2024) (0)
Mar 5, 2024 467 REDACTED VERSION of (557 in 1:21-cv-00691-GBW, 441 in 1:21-cv-01594-GBW, 443 in 1:21-cv-01138-GBW) Letter by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 03/05/2024) (30)
Mar 4, 2024 462 REDACTED VERSION of (553 in 1:21-cv-00691-GBW, 439 in 1:21-cv-01138-GBW, 437 in 1:21-cv-01594-GBW) Letter by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 03/04/2024) (5)
Mar 4, 2024 463 REDACTED VERSION of (554 in 1:21-cv-00691-GBW, 438 in 1:21-cv-01594-GBW, 440 in 1:21-cv-01138-GBW) Exhibit to a Document,, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 03/04/2024) (30)
Mar 1, 2024 458 Final Jury Instructions. (ntl) (Entered: 03/01/2024) (30)
Mar 1, 2024 459 VERDICT FORM. (ntl) (Entered: 03/01/2024) (12)
Mar 1, 2024 460 REDACTED PUBLIC VERSION of 425 Memorandum Opinion. (ntl) (Entered: 03/01/2024) (30)
Mar 1, 2024 461 REDACTED PUBLIC VERSION of 426 Order. (ntl) (Entered: 03/01/2024) (14)
Feb 29, 2024 455 Joint Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding redacted versions of the Court's sealed 02/14/24 Opinion and Order - re (540 in 1:21-cv-00691-GBW, 424 in 1:21-cv-01594-GBW, 426 in 1:21-cv-01138-GBW) Order, (425 in 1:21-cv-01138-GBW, 539 in 1:21-cv-00691-GBW, 423 in 1:21-cv-01594-GBW) Memorandum Opinion,. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 02/29/2024) (0)
Feb 29, 2024 456 SO ORDERED, re (446 in 1:21-cv-01594-GBW, 562 in 1:21-cv-00691-GBW, 448 in 1:21-cv-01138-GBW) MOTION for Limited Exemption of Person from the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 2/29/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/29/2024) (3)
Feb 29, 2024 457 ORDER re (450 in 1:21-cv-01594-GBW, 566 in 1:21-cv-00691-GBW, 452 in 1:21-cv-01138-GBW) Unopposed MOTION for exemption of persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. Signed by Judge Gregory B. Williams on 2/29/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/29/2024) (2)
Feb 28, 2024 447 SO ORDERED, re (560 in 1:21-cv-00691-GBW, 444 in 1:21-cv-01594-GBW, 446 in 1:21-cv-01138-GBW) Unopposed MOTION for Limited Exemption of Person from the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 2/28/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/28/2024) (3)
Feb 28, 2024 448 MOTION for Limited Exemption of Person from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/28/2024) (3)
Feb 28, 2024 449 VERDICT SHEET by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC Avadel's Proposed Verdict Sheet. (Joyce, Alexandra) (Entered: 02/28/2024) (9)
Feb 28, 2024 450 VERDICT SHEET by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. . (Tigan, Jeremy) (Main Document 450 replaced on 2/28/2024) (ntl). (Entered: 02/28/2024) (6)
Feb 28, 2024 451 Proposed Jury Instructions by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. - [Proposed] Final Jury Instructions. (Tigan, Jeremy) (Entered: 02/28/2024) (30)
Feb 28, 2024 452 Unopposed MOTION for exemption of persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 02/28/2024) (5)
Feb 28, 2024 453 REDACTED VERSION of (419 in 1:21-cv-01594-GBW, 535 in 1:21-cv-00691-GBW, 421 in 1:21-cv-01138-GBW) Proposed Pretrial Order by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-16)(Tigan, Jeremy) (Entered: 02/28/2024) (0)
Feb 28, 2024 454 REDACTED VERSION of (425 in 1:21-cv-01594-GBW, 427 in 1:21-cv-01138-GBW, 541 in 1:21-cv-00691-GBW) Exhibit to a Document, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 9, # 3 Exhibit 10)(Tigan, Jeremy) (Entered: 02/28/2024) (0)
Feb 27, 2024 446 Unopposed MOTION for Limited Exemption of Person from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Clark, Cameron) (Entered: 02/27/2024) (3)
Feb 26, 2024 443 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Evidentiary Dispute on Inventorship. (Attachments: # 1 Exhibits A-C, # 2 Certificate of Service)(Silver, Daniel) (Entered: 02/26/2024) (0)
Feb 26, 2024 444 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding blood level claims. (Attachments: # 1 Exhibits A-B)(Tigan, Jeremy) (Entered: 02/26/2024) (0)
Feb 26, 2024 445 ORDER re (441 in 1:21-cv-01138-GBW, 555 in 1:21-cv-00691-GBW, 439 in 1:21-cv-01594-GBW) Unopposed MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Avadel CNS Pharmaceuticals LLC. Signed by Judge Gregory B. Williams on 2/26/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/26/2024) (2)
Feb 25, 2024 439 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Defendant's Opposition to Plaintiffs' February 24, 2024 Letter of Evidentiary Disputes. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 02/25/2024) (0)
Feb 25, 2024 440 [SEALED] EXHIBIT re (439 in 1:21-cv-01138-GBW, 553 in 1:21-cv-00691-GBW, 437 in 1:21-cv-01594-GBW) Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Defendant's Opposition to Plaintiff's February 24, 2024 Letter on Evidentiary Disputes by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Exhibit 2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5, # 5 Exhibit 6, # 6 Exhibit 7, # 7 Exhibit 8, # 8 Exhibit 9, # 9 Exhibit 10, # 10 Exhibit 11, # 11 Certificate of Service)(Silver, Daniel) (Entered: 02/25/2024) (0)
Feb 25, 2024 441 Unopposed MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Proposed Order)(Joyce, Alexandra) (Entered: 02/25/2024) (0)
Feb 25, 2024 442 Letter to The Honorable Gregory B. Williams from Daniel M. Silver, Esq. regarding Resolution of Certain Evidentiary Disputes for Trial Beginning on Monday, February 26, 2024. (Silver, Daniel) (Entered: 02/25/2024) (2)
Feb 24, 2024 438 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Recurring Evidentiary Objections and Disputes. (Attachments: # 1 Exhibits A-L)(Tigan, Jeremy) (Entered: 02/24/2024) (0)
Feb 23, 2024 435 SO ORDERED, re (431 in 1:21-cv-01594-GBW, 547 in 1:21-cv-00691-GBW, 433 in 1:21-cv-01138-GBW) Joint MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 2/23/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/23/2024) (4)
Feb 23, 2024 436 STIPULATION of Infringement Regarding Claim 24 of U.S. Patent No. 11,147,782 by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/23/2024) (3)
Feb 23, 2024 437 Preliminary Jury Instructions. (ntl) (Entered: 02/23/2024) (20)
Feb 22, 2024 433 Joint MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Main Document 433 replaced on 2/23/2024) (ntl). (Entered: 02/22/2024) (4)
Feb 22, 2024 434 Proposed Voir Dire by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/22/2024) (8)
Feb 20, 2024 431 ORAL ORDER: Having reviewed the parties' respective letter briefs, D.I. 543 and D.I. 544 in C.A. No. 21-691, regarding Jazz's motion to limit the use of Rule 30(b)(6) deposition testimony during trial, the Court notes that live testimony is preferable to deposition testimony, Federal Rule of Civil Procedure 32(a)(3) is not without any limits, and the Court has some discretion on the issue. Accordingly, under the circumstances of this case, IT IS HEREBY ORDERED that, if Jazz's Rule 30(b)(6) witness in dispute, is available for live testimony during Avadel's case-in-chief on rebuttal, the Court will allow the use of the video excerpts from the Rule 30(b(6) depositions for impeachment purposes only. In other words, Avadel must question the witness live during Avadel's case-in-chief on rebuttal, if the witness remains available for live testimony. Only if the witness answers a question inconsistent with the prior deposition testimony may Avadel use video excerpts of the prior deposition testimony for impeachment purposes. If the Rule 30(b)(6) witness in dispute is not available for live testimony during Avadel's case-in-chief on rebuttal, then Avadel may use the designated video excerpts in place of questioning the witness live and Jazz may counter-designate. Given the parties' dispute on this issue, Mr. Allphin, in his capacity as a Rule 30(b)(6) witness, shall not be subject to the purported provision in the proposed Pretrial Order that fact witnesses will testify only once. Rather, Mr. Allphin, in his capacity as a Rule 30(b)(6) witness, will be subject to being called by Jazz during its case-in-chief and called subsequently by Avadel during its case-in-chief. The Court's understanding is that the instant dispute concerned Mr. Allphin in his capacity as a Rule 30(b)(6) witness and did not involve any other witnesses. If there are other witnesses for which the same dispute applies, the parties shall advise the Court and the other side in writing by no later than Noon ET on February 21, 2024, and the same rules shall apply to those witnesses unless otherwise determined by the Court. ORDERED by Judge Gregory B. Williams on 2/20/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/20/2024) (0)
Feb 20, 2024 432 STIPULATION TO EXTEND TIME to submit redacted versions of DIs 535, 539 and 540 to February 22, 2024 - filed by Avadel CNS Pharmaceuticals LLC. (Joyce, Alexandra) (Entered: 02/20/2024) (2)
Feb 19, 2024 430 Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding 30(b)(6) Deposition Testimony at Trial. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Silver, Daniel) (Entered: 02/19/2024) (0)
Feb 16, 2024 429 Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding 30(b)(6) deposition testimony dispute. (Tigan, Jeremy) (Entered: 02/16/2024) (3)
Feb 15, 2024 428 STIPULATION TO EXTEND TIME for the parties to file a redacted version of their Proposed Pretrial Order to February 19, 2024 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/15/2024) (2)
Feb 14, 2024 425 [SEALED] MEMORANDUM OPINION regarding summary judgment and Daubert motions. Signed by Judge Gregory B. Williams on 2/14/24.This document has been emailed to Delaware counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/14/2024) (0)
Feb 14, 2024 426 [SEALED] ORDER regarding motions in limine. Signed by Judge Gregory B. Williams on 2/14/24.This order has been emailed to Delaware counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/14/2024) (0)
Feb 14, 2024 427 [SEALED] EXHIBIT re (535 in 1:21-cv-00691-GBW, 419 in 1:21-cv-01594-GBW, 421 in 1:21-cv-01138-GBW) Proposed Pretrial Order -- Exhibits 8, 9 and 10 to the [Proposed] Joint Pretrial Order -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 8, # 2 Exhibit 9, # 3 Exhibit 10)(Tigan, Jeremy) (Entered: 02/14/2024) (0)
Feb 13, 2024 424 NOTICE OF SERVICE of Supplemental Expert Report of Christine S. Meyer, Ph.D. filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 02/13/2024) (3)
Feb 10, 2024 423 Joint Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Certain Pending Motions. (Tigan, Jeremy) (Entered: 02/10/2024) (2)
Feb 9, 2024 422 SO ORDERED, re (418 in 1:21-cv-01594-GBW, 420 in 1:21-cv-01138-GBW, 534 in 1:21-cv-00691-GBW) Unopposed MOTION for Limited Exemption of Person from the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 2/9/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/09/2024) (3)
Feb 8, 2024 419 SO ORDERED, re (414 in 1:21-cv-01594-GBW, 416 in 1:21-cv-01138-GBW, 530 in 1:21-cv-00691-GBW) Unopposed MOTION for Limited Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 2/8/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/08/2024) (3)
Feb 8, 2024 420 Unopposed MOTION for Limited Exemption of Person from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/08/2024) (3)
Feb 8, 2024 421 [SEALED] Proposed Pretrial Order by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-16)(Tigan, Jeremy) (Entered: 02/08/2024) (0)
Feb 7, 2024 416 Unopposed MOTION for Limited Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/07/2024) (3)
Feb 7, 2024 417 ORAL ORDER: The Court has reviewed the parties' letter, D.I. 524, jointly requesting to conduct jury selection on Friday, February 23, 2024 for the trial scheduled to begin on Monday, February 26, 2024. The Court will grant the request in this instance with the modification that the Court will conduct voir dire, jury selection and preliminary jury instructions on Friday, February 23, 2024, beginning at 10:00 am. The Court remains sensitive to the fact and reminds counsel that, although jury service is a civic duty, many employers do not compensate their employees during jury service and extending the length of jury service may increase the financial loss for some jurors. Thus, going forward, counsel should not expect the request granted in this instance or conducting voir dire and selecting the jury on any day other than the first day of trial to become routine. ORDERED by Judge Gregory B. Williams on 2/7/24. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/07/2024) (0)
Feb 7, 2024 418 NOTICE OF SERVICE of Second Supplemented Expert Report of Steven R. Little, Ph.D. filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 02/07/2024) (7)
Feb 6, 2024 411 VERDICT SHEET by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC Avadel's Proposed Verdict Form. (Joyce, Alexandra) (Entered: 02/06/2024) (10)
Feb 6, 2024 412 Proposed Jury Instructions by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Preliminary). (Tigan, Jeremy) (Entered: 02/06/2024) (21)
Feb 6, 2024 413 VERDICT SHEET by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. . (Tigan, Jeremy) (Entered: 02/06/2024) (6)
Feb 6, 2024 414 Proposed Voir Dire by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 02/06/2024) (8)
Feb 6, 2024 415 Proposed Jury Instructions by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Final). (Tigan, Jeremy) (Entered: 02/06/2024) (30)
Jan 30, 2024 405 MOTION for Pro Hac Vice Appearance of Attorney Kelly Welsh and Laryssa Bedley - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/30/2024) (4)
Jan 30, 2024 406 Pro Hac Vice Fee - Credit Card Payment received for Kelly Welsh and Laryssa Bedley. ( re 405 MOTION for Pro Hac Vice Appearance of Attorney Kelly Welsh and Laryssa Bedley )( Payment of $ 100, receipt number ADEDC-4325444).(Joyce, Alexandra) (Entered: 01/30/2024) (0)
Jan 30, 2024 407 MOTION for Pro Hac Vice Appearance of Attorney Ramya Sri Vallabhaneni - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 01/30/2024) (3)
Jan 30, 2024 408 Pro Hac Vice Fee - Credit Card Payment received for Ramya Sri Vallabhaneni. ( re 407 MOTION for Pro Hac Vice Appearance of Attorney Ramya Sri Vallabhaneni )( Payment of $ 50, receipt number ADEDC-4325680).(Silver, Daniel) (Entered: 01/30/2024) (0)
Jan 30, 2024 409 MOTION for Pro Hac Vice Appearance of Attorney Michelle Chin - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/30/2024) (3)
Jan 30, 2024 410 Pro Hac Vice Fee - Credit Card Payment received for Michelle Chin. ( re 409 MOTION for Pro Hac Vice Appearance of Attorney Michelle Chin )( Payment of $ 50, receipt number ADEDC-4326033).(Joyce, Alexandra) (Entered: 01/30/2024) (0)
Jan 26, 2024 402 MOTION for Pro Hac Vice Appearance of Attorney Scott F. Llewellyn and Umeet K. Sajjan - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 01/26/2024) (4)
Jan 26, 2024 403 Pro Hac Vice Fee - Credit Card Payment received for Scott F. Llewellyn and Umeet K. Sajjan. ( re 402 MOTION for Pro Hac Vice Appearance of Attorney Scott F. Llewellyn and Umeet K. Sajjan )( Payment of $ 100, receipt number ADEDC-4323111).(Silver, Daniel) (Entered: 01/26/2024) (0)
Jan 26, 2024 404 NOTICE OF SERVICE of Avadel's Notice of Prior Art Under 35 USC § 282 filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 01/26/2024) (3)
Jan 17, 2024 401 STIPULATION and [Proposed] Order regarding the Food and Drug Administration's Application Review Files for Lumryz by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/17/2024) (4)
Jan 10, 2024 365 REDACTED VERSION of (308 in 1:21-cv-01594-GBW) Answering Brief in Opposition,,,, (418 in 1:21-cv-00691-GBW) Answering Brief in Opposition,,,, (309 in 1:21-cv-01138-GBW) Answering Brief in Opposition,,,, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (30)
Jan 10, 2024 366 REDACTED VERSION of (303 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (305 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (416 in 1:21-cv-00691-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (21)
Jan 10, 2024 367 REDACTED VERSION of (315 in 1:21-cv-01138-GBW, 313 in 1:21-cv-01594-GBW, 426 in 1:21-cv-00691-GBW) Statement, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (6)
Jan 10, 2024 368 REDACTED VERSION of (306 in 1:21-cv-01594-GBW, 308 in 1:21-cv-01138-GBW, 420 in 1:21-cv-00691-GBW) Statement, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (14)
Jan 10, 2024 369 REDACTED VERSION of (421 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (310 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (307 in 1:21-cv-01594-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (21)
Jan 10, 2024 370 REDACTED VERSION of (428 in 1:21-cv-00691-GBW, 314 in 1:21-cv-01594-GBW, 316 in 1:21-cv-01138-GBW) Statement, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (8)
Jan 10, 2024 371 REDACTED VERSION of (429 in 1:21-cv-00691-GBW, 318 in 1:21-cv-01138-GBW, 316 in 1:21-cv-01594-GBW) Statement, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (5)
Jan 10, 2024 372 REDACTED VERSION of (422 in 1:21-cv-00691-GBW, 309 in 1:21-cv-01594-GBW, 311 in 1:21-cv-01138-GBW) Statement, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (15)
Jan 10, 2024 373 REDACTED VERSION of (431 in 1:21-cv-00691-GBW, 318 in 1:21-cv-01594-GBW, 320 in 1:21-cv-01138-GBW) Statement, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (5)
Jan 10, 2024 374 REDACTED VERSION of (312 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (423 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (310 in 1:21-cv-01594-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (12)
Jan 10, 2024 375 REDACTED VERSION of (432 in 1:21-cv-00691-GBW, 319 in 1:21-cv-01594-GBW, 321 in 1:21-cv-01138-GBW) Statement,, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (6)
Jan 10, 2024 376 REDACTED VERSION of (311 in 1:21-cv-01594-GBW, 424 in 1:21-cv-00691-GBW, 313 in 1:21-cv-01138-GBW) Statement, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (11)
Jan 10, 2024 377 REDACTED VERSION of (312 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (425 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (314 in 1:21-cv-01138-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (15)
Jan 10, 2024 378 REDACTED VERSION of (324 in 1:21-cv-01138-GBW, 435 in 1:21-cv-00691-GBW, 322 in 1:21-cv-01594-GBW) Statement,, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (5)
Jan 10, 2024 379 REDACTED VERSION of (317 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (427 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (315 in 1:21-cv-01594-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (11)
Jan 10, 2024 380 REDACTED VERSION of (319 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (317 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (430 in 1:21-cv-00691-GBW) Answering Brief in Opposition, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (12)
Jan 10, 2024 381 REDACTED VERSION of (323 in 1:21-cv-01594-GBW, 325 in 1:21-cv-01138-GBW, 436 in 1:21-cv-00691-GBW) Statement,, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (5)
Jan 10, 2024 382 REDACTED VERSION of (324 in 1:21-cv-01594-GBW, 326 in 1:21-cv-01138-GBW, 437 in 1:21-cv-00691-GBW) Statement,, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (3)
Jan 10, 2024 383 REDACTED VERSION of (320 in 1:21-cv-01594-GBW, 433 in 1:21-cv-00691-GBW, 322 in 1:21-cv-01138-GBW) Appendix,,,,, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 49-58A)(Tigan, Jeremy) (Entered: 01/10/2024) (0)
Jan 10, 2024 384 REDACTED VERSION of (438 in 1:21-cv-00691-GBW, 325 in 1:21-cv-01594-GBW, 327 in 1:21-cv-01138-GBW) Declaration,,,, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Exhibits 30-43, # 2 Exhibits 44-63)(Joyce, Alexandra) (Entered: 01/10/2024) (0)
Jan 10, 2024 385 REDACTED VERSION of (321 in 1:21-cv-01594-GBW, 323 in 1:21-cv-01138-GBW, 434 in 1:21-cv-00691-GBW) Appendix, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 59-68)(Tigan, Jeremy) (Entered: 01/10/2024) (0)
Jan 10, 2024 386 REDACTED VERSION of (469 in 1:21-cv-00691-GBW, 355 in 1:21-cv-01594-GBW, 357 in 1:21-cv-01138-GBW) Statement, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (5)
Jan 10, 2024 387 REDACTED VERSION of (359 in 1:21-cv-01138-GBW, 471 in 1:21-cv-00691-GBW, 356 in 1:21-cv-01594-GBW) Statement, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (5)
Jan 10, 2024 388 REDACTED VERSION of (459 in 1:21-cv-00691-GBW) Reply Brief, (346 in 1:21-cv-01594-GBW) Reply Brief, (348 in 1:21-cv-01138-GBW) Reply Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (8)
Jan 10, 2024 389 REDACTED VERSION of (347 in 1:21-cv-01594-GBW) Reply Brief, (460 in 1:21-cv-00691-GBW) Reply Brief, (349 in 1:21-cv-01138-GBW) Reply Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (4)
Jan 10, 2024 390 REDACTED VERSION of (360 in 1:21-cv-01594-GBW) Reply Brief, (473 in 1:21-cv-00691-GBW) Reply Brief, (362 in 1:21-cv-01138-GBW) Reply Brief by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/10/2024) (30)
Jan 10, 2024 391 REDACTED VERSION of (348 in 1:21-cv-01594-GBW) Reply Brief, (461 in 1:21-cv-00691-GBW) Reply Brief, (350 in 1:21-cv-01138-GBW) Reply Brief, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (11)
Jan 10, 2024 392 REDACTED VERSION of (462 in 1:21-cv-00691-GBW) Reply Brief, (351 in 1:21-cv-01138-GBW) Reply Brief, (349 in 1:21-cv-01594-GBW) Reply Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (10)
Jan 10, 2024 393 REDACTED VERSION of (352 in 1:21-cv-01138-GBW) Reply Brief, (463 in 1:21-cv-00691-GBW) Reply Brief, (350 in 1:21-cv-01594-GBW) Reply Brief, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (8)
Jan 10, 2024 394 REDACTED VERSION of (464 in 1:21-cv-00691-GBW) Reply Brief, (353 in 1:21-cv-01138-GBW) Reply Brief, (351 in 1:21-cv-01594-GBW) Reply Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (7)
Jan 10, 2024 395 REDACTED VERSION of (352 in 1:21-cv-01594-GBW) Reply Brief, (465 in 1:21-cv-00691-GBW) Reply Brief, (355 in 1:21-cv-01138-GBW) Reply Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (8)
Jan 10, 2024 396 REDACTED VERSION of (354 in 1:21-cv-01138-GBW) Statement, (466 in 1:21-cv-00691-GBW) Statement, (353 in 1:21-cv-01594-GBW) Statement by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (5)
Jan 10, 2024 397 REDACTED VERSION of (467 in 1:21-cv-00691-GBW) Statement, (354 in 1:21-cv-01594-GBW) Statement, (356 in 1:21-cv-01138-GBW) Statement by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (5)
Jan 10, 2024 398 REDACTED VERSION of (358 in 1:21-cv-01138-GBW) Statement, (357 in 1:21-cv-01594-GBW) Statement, (468 in 1:21-cv-00691-GBW) Statement by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (4)
Jan 10, 2024 399 REDACTED VERSION of (470 in 1:21-cv-00691-GBW) Statement, (358 in 1:21-cv-01594-GBW) Statement, (360 in 1:21-cv-01138-GBW) Statement by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/10/2024) (3)
Jan 10, 2024 400 REDACTED VERSION of (359 in 1:21-cv-01594-GBW, 361 in 1:21-cv-01138-GBW, 472 in 1:21-cv-00691-GBW) Appendix,,,, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 69-72)(Tigan, Jeremy) (Entered: 01/10/2024) (0)
Jan 8, 2024 364 STIPULATION TO EXTEND TIME for the parties to file redacted versions of certain documents to January 10, 2024 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/08/2024) (5)
Dec 26, 2023 363 STIPULATION TO EXTEND TIME to file public redacted filings to January 8, 2024 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 12/26/2023) (6)
Dec 22, 2023 347 NOTICE of withdrawal of Avadel's Motion for Summary Judgment No. 3 regarding non-infringement by Avadel CNS Pharmaceuticals LLC (Joyce, Alexandra) (Entered: 12/22/2023) (2)
Dec 22, 2023 348 [SEALED] REPLY BRIEF re 276 MOTION to Exclude Expert Testimony of Dr. Cory J. Berkland and Dr. Robert S. Langer filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 349 [SEALED] REPLY BRIEF re 280 MOTION to Exclude Expert Testimony of Bruce Corser, M.D. Regarding U.S. Patent No. 11,077,079 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 350 [SEALED] REPLY BRIEF re 278 MOTION to Exclude Expert Testimony of Alexander Klibanov and Carlo Giovanni Traverso Regarding Avadel's Infringement of the Sustained Release Patents filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 351 [SEALED] REPLY BRIEF re 282 MOTION for Partial Summary Judgment No. 1 of Infringement of the Sustained Release Patents filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 352 [SEALED] REPLY BRIEF re 284 MOTION for Partial Summary Judgment No. 2 of Nonobviousness of U.S. Patent Nos. 11,077,079 and 11,147,782 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 353 [SEALED] REPLY BRIEF re 286 MOTION for Partial Summary Judgment No. 3 of Nonobviousness of the Sustained Release Patents filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 354 [SEALED] STATEMENT re 351 Reply Brief -- Concise Counter-Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 355 [SEALED] REPLY BRIEF re 289 MOTION for Partial Summary Judgment No. 4 of No Anticipation of U.S. Patent No. 11,077,079 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 356 [SEALED] STATEMENT re 352 Reply Brief, -- Concise Counter-Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 357 [SEALED] STATEMENT re (306 in 1:21-cv-01594-GBW, 308 in 1:21-cv-01138-GBW, 420 in 1:21-cv-00691-GBW) Statement, Response to Jazz's Counterstatement of Facts in Opposition to Avadel's Motion for Summary Judgment No. 1 by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 12/22/2023) (0)
Dec 22, 2023 358 [SEALED] STATEMENT re 353 Reply Brief -- Concise Counter-Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 359 [SEALED] STATEMENT re (422 in 1:21-cv-00691-GBW, 309 in 1:21-cv-01594-GBW, 311 in 1:21-cv-01138-GBW) Statement, Avadel's Response to Jazz's Counterstatement of Facts in Opposition to Avadel's Motion for Summary Judgment No. 2 by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 12/22/2023) (0)
Dec 22, 2023 360 [SEALED] STATEMENT re 355 Reply Brief -- Concise Counter-Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 361 [SEALED] APPENDIX re (347 in 1:21-cv-01594-GBW) Reply Brief, (459 in 1:21-cv-00691-GBW) Reply Brief, (461 in 1:21-cv-00691-GBW) Reply Brief, (351 in 1:21-cv-01594-GBW) Reply Brief, (460 in 1:21-cv-00691-GBW) Reply Brief, (465 in 1:21-cv-00691-GBW) Reply Brief, (463 in 1:21-cv-00691-GBW) Reply Brief, (462 in 1:21-cv-00691-GBW) Reply Brief, (349 in 1:21-cv-01138-GBW) Reply Brief, (351 in 1:21-cv-01138-GBW) Reply Brief, (349 in 1:21-cv-01594-GBW) Reply Brief, (350 in 1:21-cv-01594-GBW) Reply Brief, (464 in 1:21-cv-00691-GBW) Reply Brief, (353 in 1:21-cv-01138-GBW) Reply Brief, (348 in 1:21-cv-01594-GBW) Reply Brief, (352 in 1:21-cv-01594-GBW) Reply Brief, (346 in 1:21-cv-01594-GBW) Reply Brief, (348 in 1:21-cv-01138-GBW) Reply Brief, (352 in 1:21-cv-01138-GBW) Reply Brief, (350 in 1:21-cv-01138-GBW) Reply Brief, (355 in 1:21-cv-01138-GBW) Reply Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 69-72)(Tigan, Jeremy) (Entered: 12/22/2023) (0)
Dec 22, 2023 362 [SEALED] REPLY BRIEF re 288 MOTION for Summary Judgment and to Exclude Expert Testimony filed by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 12/22/2023) (0)
Dec 19, 2023 328 REDACTED VERSION of (291 in 1:21-cv-01138-GBW, 289 in 1:21-cv-01594-GBW, 402 in 1:21-cv-00691-GBW) Statement, Statement of Fact in Support of its Motion for Summary Judgment No. 1 by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 12/19/2023) (7)
Dec 19, 2023 329 REDACTED VERSION of (290 in 1:21-cv-01594-GBW, 292 in 1:21-cv-01138-GBW, 403 in 1:21-cv-00691-GBW) Statement, Statement of Fact in Support of its Motion for Summary Judgment No. 2 by Avadel CNS Pharmaceuticals LLC. (Silver, Daniel) (Entered: 12/19/2023) (8)
Dec 19, 2023 330 REDACTED VERSION of (405 in 1:21-cv-00691-GBW, 294 in 1:21-cv-01138-GBW, 292 in 1:21-cv-01594-GBW) Statement, Statement of Fact in Support of its Motion for Summary Judgment No. 3 by Avadel CNS Pharmaceuticals LLC. (Silver, Daniel) (Entered: 12/19/2023) (6)
Dec 19, 2023 331 REDACTED VERSION of (407 in 1:21-cv-00691-GBW) Opening Brief in Support, (296 in 1:21-cv-01594-GBW) Opening Brief in Support, (297 in 1:21-cv-01138-GBW) Opening Brief in Support, of Defendant's Summary Judgment and Daubert Motions by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 12/19/2023) (30)
Dec 19, 2023 332 REDACTED VERSION of (302 in 1:21-cv-01138-GBW, 300 in 1:21-cv-01594-GBW, 413 in 1:21-cv-00691-GBW) Declaration,,, Declaration of Daniel M. Silver in Support of Defendant's Motions for Summary Judgments and Daubert Motions by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Exhibits 1-10, # 2 Exhibits 11-20, # 3 Exhibits 21-29)(Silver, Daniel) (Entered: 12/19/2023) (0)
Dec 19, 2023 333 REDACTED VERSION of (275 in 1:21-cv-01594-GBW) Opening Brief in Support, (388 in 1:21-cv-00691-GBW) Opening Brief in Support, (277 in 1:21-cv-01138-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (16)
Dec 19, 2023 334 REDACTED VERSION of (279 in 1:21-cv-01594-GBW) Opening Brief in Support, (281 in 1:21-cv-01138-GBW) Opening Brief in Support, (392 in 1:21-cv-00691-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (11)
Dec 19, 2023 335 REDACTED VERSION of (277 in 1:21-cv-01594-GBW) Opening Brief in Support, (390 in 1:21-cv-00691-GBW) Opening Brief in Support, (279 in 1:21-cv-01138-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (12)
Dec 19, 2023 336 REDACTED VERSION of (281 in 1:21-cv-01594-GBW) Opening Brief in Support, (283 in 1:21-cv-01138-GBW) Opening Brief in Support, (394 in 1:21-cv-00691-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (12)
Dec 19, 2023 337 REDACTED VERSION of (396 in 1:21-cv-00691-GBW) Opening Brief in Support, (285 in 1:21-cv-01138-GBW) Opening Brief in Support, (283 in 1:21-cv-01594-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (14)
Dec 19, 2023 338 REDACTED VERSION of (398 in 1:21-cv-00691-GBW) Opening Brief in Support, (286 in 1:21-cv-01594-GBW) Opening Brief in Support, (287 in 1:21-cv-01138-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (10)
Dec 19, 2023 339 REDACTED VERSION of (290 in 1:21-cv-01138-GBW) Opening Brief in Support, (288 in 1:21-cv-01594-GBW) Opening Brief in Support, (401 in 1:21-cv-00691-GBW) Opening Brief in Support, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (10)
Dec 19, 2023 340 REDACTED VERSION of (291 in 1:21-cv-01594-GBW, 293 in 1:21-cv-01138-GBW, 404 in 1:21-cv-00691-GBW) Statement, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (11)
Dec 19, 2023 341 REDACTED VERSION of (406 in 1:21-cv-00691-GBW, 293 in 1:21-cv-01594-GBW, 295 in 1:21-cv-01138-GBW) Statement,, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (11)
Dec 19, 2023 342 REDACTED VERSION of (296 in 1:21-cv-01138-GBW, 408 in 1:21-cv-00691-GBW, 294 in 1:21-cv-01594-GBW) Statement,, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (9)
Dec 19, 2023 343 REDACTED VERSION of (409 in 1:21-cv-00691-GBW, 295 in 1:21-cv-01594-GBW, 298 in 1:21-cv-01138-GBW) Statement, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/19/2023) (9)
Dec 19, 2023 344 REDACTED VERSION of (410 in 1:21-cv-00691-GBW, 299 in 1:21-cv-01138-GBW, 297 in 1:21-cv-01594-GBW) Appendix,,,,,, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-18)(Tigan, Jeremy) (Entered: 12/19/2023) (0)
Dec 19, 2023 345 REDACTED VERSION of (300 in 1:21-cv-01138-GBW, 411 in 1:21-cv-00691-GBW, 298 in 1:21-cv-01594-GBW) Appendix, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 19-27A)(Tigan, Jeremy) (Entered: 12/19/2023) (0)
Dec 19, 2023 346 REDACTED VERSION of (412 in 1:21-cv-00691-GBW, 301 in 1:21-cv-01138-GBW, 299 in 1:21-cv-01594-GBW) Appendix, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 28-48)(Tigan, Jeremy) (Entered: 12/19/2023) (0)
Dec 15, 2023 305 [SEALED] ANSWERING BRIEF in Opposition re 288 MOTION for Summary Judgment and to Exclude Expert Testimony -- Opposition to Defendant's Motion for Summary Judgment No. 1 -- filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/26/2023. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 306 [SEALED] MEMORANDUM OPINION regarding claim construction. Signed by Judge Gregory B. Williams on 12/15/23. This order has been emailed to local counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00487-GBW (ntl) (Entered: 12/15/2023) (0)
Dec 15, 2023 307 [SEALED] ORDER re (304 in 1:21-cv-01594-GBW, 417 in 1:21-cv-00691-GBW, 306 in 1:21-cv-01138-GBW, 74 in 1:22-cv-00487-GBW) Memorandum Opinion regarding claim construction. Signed by Judge Gregory B. Williams on 12/15/23. This order has been emailed to local counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00487-GBW (ntl) (Entered: 12/15/2023) (0)
Dec 15, 2023 308 [SEALED] STATEMENT re (291 in 1:21-cv-01138-GBW, 289 in 1:21-cv-01594-GBW, 402 in 1:21-cv-00691-GBW) Statement, -- Plaintiffs' Response to Defendant's Concise Statement of Facts in Support of its Motion for Summary Judgment No. 1 -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 309 [SEALED] ANSWERING BRIEF in Opposition re 286 MOTION for Partial Summary Judgment No. 3 of Nonobviousness of the Sustained Release Patents , 276 MOTION to Exclude Expert Testimony of Dr. Cory J. Berkland and Dr. Robert S. Langer , 278 MOTION to Exclude Expert Testimony of Alexander Klibanov and Carlo Giovanni Traverso Regarding Avadel's Infringement of the Sustained Release Patents , 282 MOTION for Partial Summary Judgment No. 1 of Infringement of the Sustained Release Patents , 289 MOTION for Partial Summary Judgment No. 4 of No Anticipation of U.S. Patent No. 11,077,079 , 284 MOTION for Partial Summary Judgment No. 2 of Nonobviousness of U.S. Patent Nos. 11,077,079 and 11,147,782 , 280 MOTION to Exclude Expert Testimony of Bruce Corser, M.D. Regarding U.S. Patent No. 11,077,079 filed by Avadel CNS Pharmaceuticals LLC.Reply Brief due date per Local Rules is 12/26/2023. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 310 [SEALED] ANSWERING BRIEF in Opposition re 288 MOTION for Summary Judgment and to Exclude Expert Testimony -- Opposition to Defendant's Motion for Summary Judgment No. 2 -- filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/26/2023. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 311 [SEALED] STATEMENT re (290 in 1:21-cv-01594-GBW, 292 in 1:21-cv-01138-GBW, 403 in 1:21-cv-00691-GBW) Statement, -- Plaintiffs' Response to Defendant's Concise Statement of Facts in Support of its Motion for Summary Judgment No. 2 -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 312 [SEALED] ANSWERING BRIEF in Opposition re 288 MOTION for Summary Judgment and to Exclude Expert Testimony -- Opposition to Defendant's Motion for Summary Judgment No. 3 -- filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/26/2023. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 313 [SEALED] STATEMENT re (405 in 1:21-cv-00691-GBW, 294 in 1:21-cv-01138-GBW, 292 in 1:21-cv-01594-GBW) Statement, -- Plaintiffs' Response to Defendant's Concise Statement of Facts in Support of its Motion for Summary Judgment No. 3 -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 314 [SEALED] ANSWERING BRIEF in Opposition re 288 MOTION for Summary Judgment and to Exclude Expert Testimony -- Opposition to Defendant's Motion to Exclude Expert Testimony of Mark Rainey, Ph.D. -- filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/26/2023. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 315 [SEALED] STATEMENT re (291 in 1:21-cv-01594-GBW, 293 in 1:21-cv-01138-GBW, 404 in 1:21-cv-00691-GBW) Statement, Avadel's Response to Jazz's Concise Statment of Facts in Support of Jazz's Motion for Partial Summary Judgment No. 1 of Infringment of the Sustained Release Patents by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 316 [SEALED] STATEMENT re (406 in 1:21-cv-00691-GBW, 293 in 1:21-cv-01594-GBW, 295 in 1:21-cv-01138-GBW) Statement,, Avadel's Responses to Jazz's Concise Statement of Facts in Support of Jazz's Motion for Partial Summary Judgment No. 2 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 317 [SEALED] ANSWERING BRIEF in Opposition re 288 MOTION for Summary Judgment and to Exclude Expert Testimony -- Opposition to Defendant's Motion to Exclude Expert Testimony of Christian Moreton, Ph.D. -- filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/26/2023. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 318 [SEALED] STATEMENT re (296 in 1:21-cv-01138-GBW, 408 in 1:21-cv-00691-GBW, 294 in 1:21-cv-01594-GBW) Statement,, Avadel's Responses to Jazz's Concise Statement of Facts in Support of Jazz's Motion for Partial Summary Judgment No. 3 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 319 [SEALED] ANSWERING BRIEF in Opposition re 288 MOTION for Summary Judgment and to Exclude Expert Testimony -- Opposition to Defendant's Motion to Exclude Expert Testimony of Steven Little, Ph.D. -- filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/26/2023. (Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 320 [SEALED] STATEMENT re (409 in 1:21-cv-00691-GBW, 295 in 1:21-cv-01594-GBW, 298 in 1:21-cv-01138-GBW) Statement, Avadel's Responses to Jazz's Concise Statement of Facts in Support of Jazz's Motion for Summary Judgment No. 4 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 321 [SEALED] STATEMENT re (291 in 1:21-cv-01594-GBW, 293 in 1:21-cv-01138-GBW, 404 in 1:21-cv-00691-GBW) Statement, (308 in 1:21-cv-01594-GBW) Answering Brief in Opposition,,,, (418 in 1:21-cv-00691-GBW) Answering Brief in Opposition,,,, (309 in 1:21-cv-01138-GBW) Answering Brief in Opposition,,,, Avadel's Concise Statement of Facts in Support of Its Opposition to Jazz's Motion for Partial Summary Judgment No. 1 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 322 [SEALED] APPENDIX re (317 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (303 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (305 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (421 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (430 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (310 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (312 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (423 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (312 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (310 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (425 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (314 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (319 in 1:21-cv-01138-GBW) Answering Brief in Opposition, (317 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (427 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (416 in 1:21-cv-00691-GBW) Answering Brief in Opposition, (307 in 1:21-cv-01594-GBW) Answering Brief in Opposition, (315 in 1:21-cv-01594-GBW) Answering Brief in Opposition, -- Appendix of Exhibits in Support of Plaintiffs' Oppositions to Avadel's Summary Judgment and Daubert Motions (Volume 1 of 2) -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 49-58A)(Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 323 [SEALED] APPENDIX re (320 in 1:21-cv-01594-GBW, 433 in 1:21-cv-00691-GBW, 322 in 1:21-cv-01138-GBW) Appendix,,,,, -- Appendix of Exhibits in Support of Plaintiffs' Oppositions to Avadel's Summary Judgment and Daubert Motions (Volume 2 of 2) -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 59-68)(Tigan, Jeremy) (Entered: 12/15/2023) (0)
Dec 15, 2023 324 [SEALED] STATEMENT re (406 in 1:21-cv-00691-GBW, 293 in 1:21-cv-01594-GBW, 295 in 1:21-cv-01138-GBW) Statement,, (308 in 1:21-cv-01594-GBW) Answering Brief in Opposition,,,, (418 in 1:21-cv-00691-GBW) Answering Brief in Opposition,,,, (309 in 1:21-cv-01138-GBW) Answering Brief in Opposition,,,, Avadel's Concise Counter-Statement of Facts in Opposition to Jazz's Motion for Summary Judgment No. 2 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 325 [SEALED] STATEMENT re (308 in 1:21-cv-01594-GBW) Answering Brief in Opposition,,,, (418 in 1:21-cv-00691-GBW) Answering Brief in Opposition,,,, (296 in 1:21-cv-01138-GBW, 408 in 1:21-cv-00691-GBW, 294 in 1:21-cv-01594-GBW) Statement,, (309 in 1:21-cv-01138-GBW) Answering Brief in Opposition,,,, Avadel's Concise Counter-Statement of Facts in Opposition to Jazz's Motion for Summary Judgment No. 3 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 326 [SEALED] STATEMENT re (409 in 1:21-cv-00691-GBW, 295 in 1:21-cv-01594-GBW, 298 in 1:21-cv-01138-GBW) Statement, (308 in 1:21-cv-01594-GBW) Answering Brief in Opposition,,,, (418 in 1:21-cv-00691-GBW) Answering Brief in Opposition,,,, (309 in 1:21-cv-01138-GBW) Answering Brief in Opposition,,,, Avadel's Concise Counter-Statement of Facts in Opposition to Jazz's Motion for Summary Judgment No. 4 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 15, 2023 327 [SEALED] DECLARATION re (429 in 1:21-cv-00691-GBW, 316 in 1:21-cv-01594-GBW, 318 in 1:21-cv-01138-GBW) Statement, (308 in 1:21-cv-01594-GBW) Answering Brief in Opposition,,,, (428 in 1:21-cv-00691-GBW, 314 in 1:21-cv-01594-GBW, 316 in 1:21-cv-01138-GBW) Statement, (325 in 1:21-cv-01138-GBW, 323 in 1:21-cv-01594-GBW, 436 in 1:21-cv-00691-GBW) Statement,, (418 in 1:21-cv-00691-GBW) Answering Brief in Opposition,,,, (324 in 1:21-cv-01594-GBW, 326 in 1:21-cv-01138-GBW, 437 in 1:21-cv-00691-GBW) Statement,, (320 in 1:21-cv-01138-GBW, 431 in 1:21-cv-00691-GBW, 318 in 1:21-cv-01594-GBW) Statement, (321 in 1:21-cv-01138-GBW, 432 in 1:21-cv-00691-GBW, 319 in 1:21-cv-01594-GBW) Statement,, (322 in 1:21-cv-01594-GBW, 324 in 1:21-cv-01138-GBW, 435 in 1:21-cv-00691-GBW) Statement,, (315 in 1:21-cv-01138-GBW, 313 in 1:21-cv-01594-GBW, 426 in 1:21-cv-00691-GBW) Statement, (309 in 1:21-cv-01138-GBW) Answering Brief in Opposition,,,, Declaration of Daniel M. Silver by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Exhibits 30-43, # 2 Exhibits 44-63, # 3 Certificate of Service)(Silver, Daniel) (Entered: 12/15/2023) (0)
Dec 7, 2023 303 STIPULATION TO EXTEND TIME for: (1) the parties to file answering briefs in opposition to motions for summary judgment and Daubert motions to December 15, 2023; and (2) the parties to file reply briefs in support of motions for summary judgment and Daubert motions to December 22, 2023 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 12/07/2023) (2)
Dec 7, 2023 304 STIPULATION TO EXTEND TIME see stipulation for details to December 19, 2023 - filed by Avadel CNS Pharmaceuticals LLC. (Joyce, Alexandra) (Entered: 12/07/2023) (4)
Nov 30, 2023 275 NOTICE OF SERVICE of Defendant's Fourth Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 11/30/2023) (3)
Nov 30, 2023 276 MOTION to Exclude Expert Testimony of Dr. Cory J. Berkland and Dr. Robert S. Langer - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (5)
Nov 30, 2023 277 [SEALED] OPENING BRIEF in Support re 276 MOTION to Exclude Expert Testimony of Dr. Cory J. Berkland and Dr. Robert S. Langer filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 12/14/2023. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 278 MOTION to Exclude Expert Testimony of Alexander Klibanov and Carlo Giovanni Traverso Regarding Avadel's Infringement of the Sustained Release Patents - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (6)
Nov 30, 2023 279 [SEALED] OPENING BRIEF in Support re 278 MOTION to Exclude Expert Testimony of Alexander Klibanov and Carlo Giovanni Traverso Regarding Avadel's Infringement of the Sustained Release Patents filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 12/14/2023. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 280 MOTION to Exclude Expert Testimony of Bruce Corser, M.D. Regarding U.S. Patent No. 11,077,079 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (5)
Nov 30, 2023 281 [SEALED] OPENING BRIEF in Support re 280 MOTION to Exclude Expert Testimony of Bruce Corser, M.D. Regarding U.S. Patent No. 11,077,079 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 12/14/2023. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 282 MOTION for Partial Summary Judgment No. 1 of Infringement of the Sustained Release Patents - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (5)
Nov 30, 2023 283 [SEALED] OPENING BRIEF in Support re 282 MOTION for Partial Summary Judgment No. 1 of Infringement of the Sustained Release Patents filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 12/14/2023. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 284 MOTION for Partial Summary Judgment No. 2 of Nonobviousness of U.S. Patent Nos. 11,077,079 and 11,147,782 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (5)
Nov 30, 2023 285 [SEALED] OPENING BRIEF in Support re 284 MOTION for Partial Summary Judgment No. 2 of Nonobviousness of U.S. Patent Nos. 11,077,079 and 11,147,782 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 12/14/2023. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 286 MOTION for Partial Summary Judgment No. 3 of Nonobviousness of the Sustained Release Patents - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (5)
Nov 30, 2023 287 [SEALED] OPENING BRIEF in Support re 286 MOTION for Partial Summary Judgment No. 3 of Nonobviousness of the Sustained Release Patents filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 12/14/2023. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 288 MOTION for Summary Judgment and to Exclude Expert Testimony - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # 1 Text of Proposed Order, # 2 Rule 7.1.1. Certification)(Silver, Daniel) (Entered: 11/30/2023) (0)
Nov 30, 2023 289 MOTION for Partial Summary Judgment No. 4 of No Anticipation of U.S. Patent No. 11,077,079 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (5)
Nov 30, 2023 290 [SEALED] OPENING BRIEF in Support re 289 MOTION for Partial Summary Judgment No. 4 of No Anticipation of U.S. Patent No. 11,077,079 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..Answering Brief/Response due date per Local Rules is 12/14/2023. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 291 [SEALED] STATEMENT re (399 in 1:21-cv-00691-GBW, 285 in 1:21-cv-01594-GBW, 288 in 1:21-cv-01138-GBW) MOTION for Summary Judgment and to Exclude Expert Testimony Statement of Fact in Support of its Motion for Summary Judgment No. 1 by Avadel CNS Pharmaceuticals LLC. (Silver, Daniel) (Additional attachment(s) added on 12/1/2023: # 2 Certificate of Service) (ntl). (Entered: 11/30/2023) (0)
Nov 30, 2023 292 [SEALED] STATEMENT re (399 in 1:21-cv-00691-GBW, 285 in 1:21-cv-01594-GBW, 288 in 1:21-cv-01138-GBW) MOTION for Summary Judgment and to Exclude Expert Testimony Statement of Fact in Support of its Motion for Summary Judgment No. 2 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 11/30/2023) (0)
Nov 30, 2023 293 [SEALED] STATEMENT re (281 in 1:21-cv-01594-GBW) Opening Brief in Support, (282 in 1:21-cv-01138-GBW, 280 in 1:21-cv-01594-GBW, 393 in 1:21-cv-00691-GBW) MOTION for Partial Summary Judgment No. 1 of Infringement of the Sustained Release Patents , (283 in 1:21-cv-01138-GBW) Opening Brief in Support, (394 in 1:21-cv-00691-GBW) Opening Brief in Support, -- Concise Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 294 [SEALED] STATEMENT re (399 in 1:21-cv-00691-GBW, 285 in 1:21-cv-01594-GBW, 288 in 1:21-cv-01138-GBW) MOTION for Summary Judgment and to Exclude Expert Testimony Statement of Fact in Support of its Motion for Summary Judgment No. 3 by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 11/30/2023) (0)
Nov 30, 2023 295 [SEALED] STATEMENT re (396 in 1:21-cv-00691-GBW) Opening Brief in Support, (285 in 1:21-cv-01138-GBW) Opening Brief in Support, (395 in 1:21-cv-00691-GBW, 284 in 1:21-cv-01138-GBW, 282 in 1:21-cv-01594-GBW) MOTION for Partial Summary Judgment No. 2 of Nonobviousness of U.S. Patent Nos. 11,077,079 and 11,147,782 , (283 in 1:21-cv-01594-GBW) Opening Brief in Support, -- Concise Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 296 [SEALED] STATEMENT re (397 in 1:21-cv-00691-GBW, 286 in 1:21-cv-01138-GBW, 284 in 1:21-cv-01594-GBW) MOTION for Partial Summary Judgment No. 3 of Nonobviousness of the Sustained Release Patents , (398 in 1:21-cv-00691-GBW) Opening Brief in Support, (286 in 1:21-cv-01594-GBW) Opening Brief in Support, (287 in 1:21-cv-01138-GBW) Opening Brief in Support, -- Concise Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 297 [SEALED] OPENING BRIEF in Support re 288 MOTION for Summary Judgment and to Exclude Expert Testimony filed by Avadel CNS Pharmaceuticals LLC.Answering Brief/Response due date per Local Rules is 12/14/2023. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 11/30/2023) (0)
Nov 30, 2023 298 [SEALED] STATEMENT re (287 in 1:21-cv-01594-GBW, 289 in 1:21-cv-01138-GBW, 400 in 1:21-cv-00691-GBW) MOTION for Partial Summary Judgment No. 4 of No Anticipation of U.S. Patent No. 11,077,079 , (290 in 1:21-cv-01138-GBW) Opening Brief in Support, (288 in 1:21-cv-01594-GBW) Opening Brief in Support, (401 in 1:21-cv-00691-GBW) Opening Brief in Support, -- Concise Statement of Facts -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 299 [SEALED] APPENDIX re (389 in 1:21-cv-00691-GBW, 278 in 1:21-cv-01138-GBW, 276 in 1:21-cv-01594-GBW) MOTION to Exclude Expert Testimony of Alexander Klibanov and Carlo Giovanni Traverso Regarding Avadel's Infringement of the Sustained Release Patents , (397 in 1:21-cv-00691-GBW, 286 in 1:21-cv-01138-GBW, 284 in 1:21-cv-01594-GBW) MOTION for Partial Summary Judgment No. 3 of Nonobviousness of the Sustained Release Patents , (287 in 1:21-cv-01594-GBW, 289 in 1:21-cv-01138-GBW, 400 in 1:21-cv-00691-GBW) MOTION for Partial Summary Judgment No. 4 of No Anticipation of U.S. Patent No. 11,077,079 , (274 in 1:21-cv-01594-GBW, 387 in 1:21-cv-00691-GBW, 276 in 1:21-cv-01138-GBW) MOTION to Exclude Expert Testimony of Dr. Cory J. Berkland and Dr. Robert S. Langer , (282 in 1:21-cv-01138-GBW, 280 in 1:21-cv-01594-GBW, 393 in 1:21-cv-00691-GBW) MOTION for Partial Summary Judgment No. 1 of Infringement of the Sustained Release Patents , (395 in 1:21-cv-00691-GBW, 284 in 1:21-cv-01138-GBW, 282 in 1:21-cv-01594-GBW) MOTION for Partial Summary Judgment No. 2 of Nonobviousness of U.S. Patent Nos. 11,077,079 and 11,147,782 , (278 in 1:21-cv-01594-GBW, 391 in 1:21-cv-00691-GBW, 280 in 1:21-cv-01138-GBW) MOTION to Exclude Expert Testimony of Bruce Corser, M.D. Regarding U.S. Patent No. 11,077,079 (Volume 1 of 3) by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-18)(Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 300 [SEALED] APPENDIX re (410 in 1:21-cv-00691-GBW, 299 in 1:21-cv-01138-GBW, 297 in 1:21-cv-01594-GBW) Appendix,,,,,, (Volume 2 of 3) by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 19-27A)(Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 301 [SEALED] APPENDIX re (300 in 1:21-cv-01138-GBW, 411 in 1:21-cv-00691-GBW, 298 in 1:21-cv-01594-GBW) Appendix, (Volume 3 of 3) by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 28-48)(Tigan, Jeremy) (Entered: 11/30/2023) (0)
Nov 30, 2023 302 [SEALED] DECLARATION re (399 in 1:21-cv-00691-GBW, 285 in 1:21-cv-01594-GBW, 288 in 1:21-cv-01138-GBW) MOTION for Summary Judgment and to Exclude Expert Testimony , (291 in 1:21-cv-01138-GBW, 289 in 1:21-cv-01594-GBW, 402 in 1:21-cv-00691-GBW) Statement, (296 in 1:21-cv-01594-GBW) Opening Brief in Support, (290 in 1:21-cv-01594-GBW, 403 in 1:21-cv-00691-GBW, 292 in 1:21-cv-01138-GBW) Statement, (405 in 1:21-cv-00691-GBW, 294 in 1:21-cv-01138-GBW, 292 in 1:21-cv-01594-GBW) Statement, (407 in 1:21-cv-00691-GBW) Opening Brief in Support, (297 in 1:21-cv-01138-GBW) Opening Brief in Support, Declaration of Daniel M. Silver by Avadel CNS Pharmaceuticals LLC. (Attachments: # 1 Exhibits 1-10, # 2 Exhibits 11-20, # 3 Exhibits 21-29, # 4 Certificate of Service)(Silver, Daniel) (Entered: 11/30/2023) (0)
Nov 9, 2023 274 MOTION for Pro Hac Vice Appearance of Attorney David F. Kowalski - filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC. (Joyce, Alexandra) (Entered: 11/09/2023) (3)
Nov 6, 2023 272 REDACTED VERSION of (269 in 1:21-cv-01138-GBW, 379 in 1:21-cv-00691-GBW, 267 in 1:21-cv-01594-GBW) Letter, by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals PLC, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc.. (Joyce, Alexandra) (Entered: 11/06/2023) (14)
Nov 6, 2023 273 REDACTED VERSION of (268 in 1:21-cv-01138-GBW, 378 in 1:21-cv-00691-GBW, 266 in 1:21-cv-01594-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Attachment 1- Dr. Charman Excerpts, # 2 Attachment 2- Klibanov Excerpts)(Tigan, Jeremy) (Entered: 11/06/2023) (0)
Nov 3, 2023 270 ORAL ORDER: Having considered the parties' respective positions on consolidation of C.A. No. 22-487 (the "trade secret case") with C.A. Nos. 21-691-GBW, 21-1138-GBW, and 21-1594-GBW (the "patent cases") (D.I. 348), IT IS HEREBY ORDERED that Avadel's motion for consolidation is DENIED. The mere existence of common issues, a prerequisite to consolidation, does not require consolidation. U.S. v. Dentsply Int'l, Inc., 190 F.R.D. 140, 143 (D.Del. 1999); Rohm & Haas Co. v. Mobil Oil Corp., 525 F. Supp. 1298, 1309 (D.Del. 1981). Indeed, the Court "must balance the savings of time and effort gained through consolidation against the inconvenience, delay or expense that might result from simultaneous disposition of the separate actions." Rohm & Haas Co., 525 F. Supp. at 1309. Here, the Court finds that any efficiency to be gained by consolidating Jazz's patent cases with Avadel's trade secret misappropriation case is outweighed by the delay that consolidation would cause to Jazz's patent cases, possible overcomplication of issues, and the potential for jury confusion. The patent cases are already consolidated, fact discovery has been completed and expert discovery is nearly complete in them, and trial in those cases is scheduled to begin on February 26, 2024. Under Avadel's proposed consolidated schedule, the trial in the further consolidated case would not begin until October 2024 at the earliest. See D.I. 348 in C.A. No. 21-00691-GBW, Attachment 1 (Avadel's proposed order). Jazz, in its opposition to the request for consolidation, disputes whether an October 2024 trial is realistic given the number of witnesses that will need to be deposed for the trade secrets case, particularly given that many of those witnesses are located overseas. See also Borough of Olyphant v. PPL Corp., 153 Fed. Appx. 80, 82 (3d Cir. 2005) ("it is within a district court's broad discretion to deny a motion to consolidate if it would cause delay in one of the cases."). Also, in the patent cases, Jazz and Avadel are already litigating infringement and invalidity issues involving six patents from two different patent families. See C.A. No. 22-cv-00487-GBW, D.I. 53 at 2. In the trade secrets case, Avadel asserts that Jazz engaged in breach of contract and trade secret misappropriation. Id.; see D.I. 2 in C.A. No. 22-cv-00487-GBW. The Court finds that the patent cases and the trade secrets case do not share enough common issues of law to justify consolidation under the circumstances. One trial to resolve all three disputes would be unwieldy and overly complex because of the number of witnesses, the amount of evidence which would need to be presented on the disparate legal theories and the six patents, and the potential for jury confusion. Accordingly, Avadel's motion for consolidation is denied. ORDERED by Judge Gregory B. Williams on 11/3/23. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00487-GBW (ntl) (Entered: 11/03/2023) (0)
Nov 3, 2023 271 NOTICE OF SERVICE of Reply Expert Report of Mark Rainey, Ph.D. filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 11/03/2023) (6)
Oct 30, 2023 268 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Supplemental Deposition Transcripts - re (247 in 1:21-cv-01138-GBW, 247 in 1:21-cv-01138-GBW, 245 in 1:21-cv-01594-GBW, 245 in 1:21-cv-01594-GBW, 356 in 1:21-cv-00691-GBW, 356 in 1:21-cv-00691-GBW) Order,, Set Hearings,. (Attachments: # 1 Excerpt of Dr. Charman Deposition Transcript, # 2 Excerpt of Dr. Klibanov Deposition Transcript)(Tigan, Jeremy) (Entered: 10/30/2023) (0)
Oct 30, 2023 269 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Supplemental Deposition Transcript Excerpts for November 1, 2023 Markman Hearing. (Attachments: # 1 Excerpts of Deposition, # 2 Certificate of Service)(Silver, Daniel) (Entered: 10/30/2023) (0)
Oct 25, 2023 267 Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding request to discuss consolidation at the conclusion of the November 1, 2023 Markman hearing. (Silver, Daniel) (Entered: 10/25/2023) (1)
Oct 23, 2023 265 REDACTED VERSION of (260 in 1:21-cv-01138-GBW) Joint Claim Construction Brief, (369 in 1:21-cv-00691-GBW) Joint Claim Construction Brief, (258 in 1:21-cv-01594-GBW) Joint Claim Construction Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 10/23/2023) (30)
Oct 23, 2023 266 REDACTED VERSION of (259 in 1:21-cv-01594-GBW, 370 in 1:21-cv-00691-GBW, 261 in 1:21-cv-01138-GBW) Appendix, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-15, # 2 Exs. A-H)(Tigan, Jeremy) (Entered: 10/23/2023) (0)
Oct 17, 2023 264 STIPULATION TO EXTEND TIME for the parties to file redacted versions of their Supplemental Joint Claim Construction Brief (D.I. 369) and Joint Appendix (D.I. 370) to October 24, 2023 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 10/17/2023) (2)
Oct 16, 2023 262 NOTICE OF SERVICE of Defendants' Third Supplemental Responses to Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited's Second Set of Interrogatories (Nos. 9-15) filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 10/16/2023) (3)
Oct 16, 2023 263 NOTICE OF SERVICE of Expert Report of Christine S. Meyers, Ph.D. and Exhibits filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 10/16/2023) (3)
Oct 10, 2023 260 [SEALED] Supplemental JOINT CLAIM CONSTRUCTION BRIEF (Second) filed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Tigan, Jeremy) (Entered: 10/10/2023) (0)
Oct 10, 2023 261 [SEALED] Joint APPENDIX re (260 in 1:21-cv-01138-GBW) Joint Claim Construction Brief, (369 in 1:21-cv-00691-GBW) Joint Claim Construction Brief, (258 in 1:21-cv-01594-GBW) Joint Claim Construction Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-15, # 2 Exhibits A-H)(Tigan, Jeremy) (Attachment 1 replaced on 10/11/2023) (ntl). (Entered: 10/10/2023) (0)
Oct 8, 2023 259 STIPULATION TO EXTEND TIME for the parties to file a joint second supplemental Markman brief to October 10, 2023 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 10/08/2023) (2)
Oct 6, 2023 258 NOTICE OF SERVICE of Avadel's Sur-Reply to Plaintiff's Second Supplemental Markman Brief and Exhibit filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 10/06/2023) (3)
Oct 4, 2023 257 MOTION for Pro Hac Vice Appearance of Attorney Raymond N. Nimrod, Christopher D. Porter, Ellyde R. Thompson, and Elizabeth M. Devaney - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 10/04/2023) (8)
Sep 22, 2023 256 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Reply Markman Brief filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/22/2023) (6)
Sep 18, 2023 255 NOTICE OF SERVICE of Expert Report of Mark Rainey, Ph.D. filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 09/18/2023) (6)
Sep 15, 2023 252 MOTION for Pro Hac Vice Appearance of Attorney Elizabeth J. Murphy - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 09/15/2023) (5)
Sep 15, 2023 253 NOTICE to Take Deposition of PJ Honerkamp on September 21, 2023 filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 09/15/2023) (2)
Sep 15, 2023 254 MOTION for Pro Hac Vice Appearance of Attorney Tannyr Pasvantis - filed by Avadel CNS Pharmaceuticals LLC. (Joyce, Alexandra) (Entered: 09/15/2023) (3)
Sep 1, 2023 250 NOTICE requesting Clerk to remove Sarah Propst as co-counsel.. (Joyce, Alexandra) (Entered: 09/01/2023) (2)
Sep 1, 2023 251 NOTICE OF SERVICE of Avadel's Opposition to Plaintiffs' Second Supplemental Markman Brief and Exhibits filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 09/01/2023) (3)
Aug 31, 2023 249 MOTION for Pro Hac Vice Appearance of Attorney Denise Laspina - filed by Avadel CNS Pharmaceuticals LLC. (Silver, Daniel) (Entered: 08/31/2023) (3)
Aug 29, 2023 248 REDACTED VERSION of (52 in 1:22-cv-00487-GBW, 239 in 1:21-cv-01138-GBW, 348 in 1:21-cv-00691-GBW, 236 in 1:21-cv-01594-GBW) Letter by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC. (Silver, Daniel) (Entered: 08/29/2023) (30)
Aug 28, 2023 247 ORAL ORDER: IT IS HEREBY ORDERED that the Markman Hearing scheduled for October 25, 2023 is RESCHEDULED for November 1, 2023 at 1:00 PM in Courtroom 6B. ORDERED by Judge Gregory B. Williams on 8/28/23. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 08/28/2023) (0)
Aug 25, 2023 246 STIPULATION TO EXTEND TIME for Certain Expert Discovery Deadlines to Various Dates - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 08/25/2023) (3)
Aug 23, 2023 245 NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendant's Eighth Set of Interrogatories (Nos. 22-25) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 08/23/2023) (6)
Aug 22, 2023 244 STIPULATION TO EXTEND TIME for Avadel CNS Pharmaceuticals LLC and Avadel Pharmaceuticals PLC to file a redacted version of their August 15, 2023 Letter to the Honorable Judge Gregory B. Williams to August 29, 2023 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 08/22/2023) (2)
Aug 21, 2023 243 NOTICE to Take Deposition of Shawn Mindus on August 30, 2023 filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 08/21/2023) (2)
Aug 18, 2023 242 NOTICE OF SERVICE of Defendant's Second Supplemental Responses to Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited's Second Set of Interrogatories (Nos. 9-15) filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 08/18/2023) (3)
Aug 17, 2023 241 NOTICE to Take Deposition of Patty Pound on August 21, 2023 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 08/17/2023) (5)
Aug 16, 2023 240 MOTION for Pro Hac Vice Appearance of Attorney Alexandra Kim - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 08/16/2023) (5)
Aug 15, 2023 238 NOTICE OF SERVICE of First Supplemental Responses to Jazz Pharmaceutical, Inc. and Jazz Pharmaceuticals Ireland Limited's Second Set of Interrogatories (Nos. 9-15) filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 08/15/2023) (3)
Aug 15, 2023 239 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Requesting Status Conference and Consolidation of Cases. (Attachments: # 1 Proposed Order, # 2 Exhibits 1-4, # 3 Certificate of Service)(Silver, Daniel) (Entered: 08/15/2023) (0)
Aug 11, 2023 237 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Opening Markman Brief filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 08/11/2023) (5)
Aug 4, 2023 236 SO ORDERED, re (340 in 1:21-cv-00691-GBW, 231 in 1:21-cv-01138-GBW, 227 in 1:21-cv-01594-GBW) Stipulation and Order Regarding Claim Construction Schedule and Hearing filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. -- Joint Claim Construction Brief due by 10/9/2023. A Markman Hearing is set for 10/25/2023 at 1:00 PM in Courtroom 6B. Signed by Judge Gregory B. Williams on 8/4/23. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 08/04/2023) (3)
Jul 31, 2023 235 AMENDED ANSWER to 227 Answer to Amended Complaint, Counterclaim by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 07/31/2023) (30)
Jul 28, 2023 234 NOTICE OF SERVICE of Jazz Pharmaceuticals' Fourth Amended Initial Disclosures filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 07/28/2023) (5)
Jul 26, 2023 233 MOTION for Pro Hac Vice Appearance of Attorney Catherine T. Mattes and Abigail DeMasi - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 07/26/2023) (6)
Jul 21, 2023 231 STIPULATION and [Proposed] Order Regarding Claim Construction Schedule & Hearing by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 07/21/2023) (3)
Jul 21, 2023 232 NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Supplemental Notice of Deposition to Avadel CNS Pharmaceuticals, LLC Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra) (Entered: 07/21/2023) (3)
Jul 17, 2023 230 Joint Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Response to the Court's July 3 and 11, 2023 Orders - re (332 in 1:21-cv-00691-GBW, 218 in 1:21-cv-01594-GBW, 223 in 1:21-cv-01138-GBW) Order, SO ORDERED,. (Tigan, Jeremy) (Entered: 07/17/2023) (1)
Jul 10, 2023 227 ANSWER to Amended Complaint, re: 216 Amended Complaint with Jury Trial Demanded , COUNTERCLAIM against Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. by Avadel CNS Pharmaceuticals LLC.(Silver, Daniel) (Entered: 07/10/2023) (30)
Jul 10, 2023 228 STIPULATION TO EXTEND TIME to submit Joint Letter Regarding Supplemental Markman Hearing to July 17, 2023 - filed by Avadel CNS Pharmaceuticals LLC. (Silver, Daniel) (Entered: 07/10/2023) (2)
Jul 10, 2023 229 NOTICE OF SERVICE of (1) Defendant's Responses and Objections to Plaintiff's Second Set of Interrogatories (Nos. 9-15), and (2) Defendant's Responses and Objections to Plaintiff's Fifth Set of Requests for Production (Nos. 82-98) filed by Avadel CNS Pharmaceuticals LLC.(Silver, Daniel) (Entered: 07/10/2023) (3)
Jul 3, 2023 221 NOTICE OF SERVICE of Reply Expert Report of Steven R. Little, Ph.D. filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 07/03/2023) (5)
Jul 3, 2023 222 SO ORDERED, re (213 in 1:21-cv-01594-GBW, 327 in 1:21-cv-00691-GBW, 218 in 1:21-cv-01138-GBW) Stipulation and Order Regarding Trial by Jury and Modifying Case Schedule -- Dispositive Motions due by 11/30/2023. A 5-day Jury Trial is set for 2/26/2024 at 09:30 AM in Courtroom 6B before Judge Gregory B. Williams. A Pretrial Conference is set for 2/15/2024 at 04:00 PM in Courtroom 6B before Judge Gregory B. Williams. Signed by Judge Gregory B. Williams on 7/3/23. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 07/03/2023) (5)
Jul 3, 2023 223 ORAL ORDER: On or before Monday, July 10, 2023, the parties shall file a joint letter explaining whether (a) they maintain their request for a Claim Construction Hearing as raised in D.I. 304, and (b) propose an approximate week or date range to hold such a Hearing. ORDERED by Judge Gregory B. Williams on 7/3/23. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 07/03/2023) (0)
Jul 3, 2023 224 NOTICE OF SERVICE of Defendant's Third Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 07/03/2023) (3)
Jul 3, 2023 225 NOTICE OF SERVICE of (1) Reply Expert Report of Robert S. Langer, (2) Reply Expert Report of Alexander M. Klibanov, Ph.D., (3) Reply Expert Report of Dr. Martin Scharf, (4) Reply Expert Report of William Charman, (5) Reply Expert Report of Bruce Corser, M.D., (6) Reply Expert Report of Dr. Cory Berkland, (7) Reply Expert Report of Joseph Matal, and (8) Reply Expert Report of Vivian Gray filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 07/03/2023) (3)
Jul 3, 2023 226 NOTICE OF SERVICE of (1) Plaintiffs' Responses and Objections to Avadel CNS Pharmaceuticals, LLC's Supplemental Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6); and (2) Plaintiffs' Objections and Responses to Defendant's Second Set of Requests for Admission (Nos. 17-66) - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 07/03/2023) (5)
Jun 29, 2023 219 NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant's Eighth Set of Interrogatories (Nos. 22-25) and (2) Plaintiffs' Objections and Responses to Defendant's Eighth Set of Requests for the Production of Documents and Things (Nos. 107-122) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 06/29/2023) (5)
Jun 29, 2023 220 NOTICE to Take Deposition of Greg Divis and David O'Brien on dates and times to be mutually agreed upon by counsel filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 06/29/2023) (4)
Jun 28, 2023 218 STIPULATION and [Proposed] Order Regarding Trial by Jury and Modifying Case Schedule by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 06/28/2023) (5)
Jun 21, 2023 217 STIPULATION TO EXTEND TIME to submit Reply Expert Reports to June 30, 2023 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 06/21/2023) (3)
Jun 9, 2023 216 Amended Complaint* (1)
Jun 8, 2023 214 STIPULATION to Amend Complaints by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit 1 - Amended Complaint C.A. 21-691, # 2 Exhibits A-F to Amended Complaint C.A. 21-691, # 3 Exhibit 2 - Amended Complaint C.A. 21-1138, # 4 Exhibits A-D to Amended Complaint C.A. 21-1138, # 5 Exhibit 3 - Amended Complaint C.A. 21-1594, # 6 Exhibits A-C to Amended Complaint C.A. 21-1594, # 7 Exhibit 4 - Redline C.A. 21-691, # 8 Exhibit 5 - Redline C.A. 21-1138, # 9 Exhibit 6 - Redline C.A. 21-1594)(Tigan, Jeremy) (Entered: 06/08/2023) (0)
Jun 8, 2023 215 NOTICE OF SERVICE of (1) Jazz Pharmaceuticals' Second Set of Interrogatories (Nos. 9-15), (2) Jazz Pharmaceuticals' Fifth Set of Requests for the Production of Documents and Things (Nos. 82-98), and (3) Plaintiffs' Supplemental Notice of Deposition to Avadel CNS Pharmaceuticals, LLC Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 06/08/2023) (5)
Jun 2, 2023 213 NOTICE OF SERVICE of (1) Defendant's Second Set of Requests for Admissions, and (2) Defendant's Supplemental Notice of Deposition of Plaintiffs Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel) (Entered: 06/02/2023) (4)
May 31, 2023 212 NOTICE OF SERVICE of (1) Defendant's Eighth Set of Requests for Production of Documents and Things to Plaintiffs, and (2) Defendant's Eighth Set of Interrogatories to Plaintiffs filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 05/31/2023) (4)
May 10, 2023 211 NOTICE OF SERVICE of Defendant's Second Amended Disclosures Pursuant to Fed. R. Civ. P. 26(A) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 05/10/2023) (3)
May 8, 2023 208 NOTICE OF SERVICE of (1) Responsive Expert Report of Richard K. Bogan, M.D., FCCP, (2) Responsive Expert Report of Martyn Christopher Davies, Ph.D., (3) Rebuttal Expert Report of David J. Greenblatt, M.D., (4) Rebuttal Expert Report of Steven R. Little, Ph.D. Regarding U.S. Patent Nos. 11,077,079 and 11,147,782, (5) Rebuttal Expert Report of Steven R. Little, Ph.D. Regarding the Sustained Release Patents, (6) Supplemental Rebuttal Expert Report of Steven R. Little, Ph.D. Regarding the Sustained Release Patents, (7) Rebuttal Expert Report of R. Christian Moreton, M.Sc, Ph.D, M.R.Pharm.S, C.Sci., (8) Rebuttal Expert Report of Adam C. Myers, Ph.D. and (9) Rebuttal Expert Report of Robert L. Stoll filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 05/08/2023) (6)
May 8, 2023 209 NOTICE OF SERVICE of (1) Responsive Expert Report of Alexander Klibanov, Ph.D., Regarding Non-Infringement, and (2) Expert Report Carlo Giovanni Traverso, Ph.D., MB, BCHIR filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 05/08/2023) (3)
May 8, 2023 210 MOTION for Pro Hac Vice Appearance of Attorney Adam R. Brausa - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 05/08/2023) (3)
May 4, 2023 205 REDACTED VERSION of (201 in 1:21-cv-01138-GBW) Joint Claim Construction Brief, (196 in 1:21-cv-01594-GBW) Joint Claim Construction Brief, (310 in 1:21-cv-00691-GBW) Joint Claim Construction Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 05/04/2023) (30)
May 4, 2023 206 REDACTED VERSION of (202 in 1:21-cv-01138-GBW, 311 in 1:21-cv-00691-GBW, 197 in 1:21-cv-01594-GBW) Appendix, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-41)(Tigan, Jeremy) (Entered: 05/04/2023) (0)
May 4, 2023 207 REDACTED VERSION of (198 in 1:21-cv-01594-GBW, 312 in 1:21-cv-00691-GBW, 203 in 1:21-cv-01138-GBW) Appendix, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-O)(Tigan, Jeremy) (Entered: 05/04/2023) (0)
May 1, 2023 204 NOTICE OF SERVICE of (1) Supplemental Expert Report of Dr. Martin Scharf, (2) Supplemental Opening Expert Report of Robert S. Langer, (3) Second Supplemented Opening Expert Report of William Charman, and (4) Second Supplemental Opening Expert Report of Alexander M. Klibonv, Ph.D. filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 05/01/2023) (3)
Apr 26, 2023 201 [SEALED] Supplemental JOINT CLAIM CONSTRUCTION BRIEF filed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Tigan, Jeremy) (Entered: 04/26/2023) (0)
Apr 26, 2023 202 [SEALED] Joint APPENDIX re (201 in 1:21-cv-01138-GBW) Joint Claim Construction Brief, (196 in 1:21-cv-01594-GBW) Joint Claim Construction Brief, (310 in 1:21-cv-00691-GBW) Joint Claim Construction Brief -- Joint Supplemental Claim Construction Appendix: Volume 1 of 2 -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-41)(Tigan, Jeremy) (Entered: 04/26/2023) (0)
Apr 26, 2023 203 [SEALED] Joint APPENDIX re (202 in 1:21-cv-01138-GBW, 311 in 1:21-cv-00691-GBW, 197 in 1:21-cv-01594-GBW) Appendix, (201 in 1:21-cv-01138-GBW) Joint Claim Construction Brief, (196 in 1:21-cv-01594-GBW) Joint Claim Construction Brief, (310 in 1:21-cv-00691-GBW) Joint Claim Construction Brief -- Joint Supplemental Claim Construction Appendix: Volume 2 of 2 -- by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-O)(Tigan, Jeremy) (Entered: 04/26/2023) (0)
Apr 25, 2023 200 NOTICE OF SERVICE of Avadel's Sur-Reply Supplemental Markman Brief filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 04/25/2023) (3)
Apr 18, 2023 199 NOTICE OF SERVICE of Plaintiffs' Supplemental Reply Markman Brief filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 04/18/2023) (5)
Apr 4, 2023 198 NOTICE OF SERVICE of Defendant's Responsive Supplemental Markman Brief and Supporting Documents filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 04/04/2023) (3)
Mar 24, 2023 197 NOTICE OF SERVICE of Plaintiffs' Supplemental Opening Markman Brief filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 03/24/2023) (5)
Mar 15, 2023 196 STIPULATION and [Proposed] Order Modifying Case Schedule by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 03/15/2023) (3)
Mar 10, 2023 194 REDACTED VERSION of (186 in 1:21-cv-01594-GBW, 191 in 1:21-cv-01138-GBW, 298 in 1:21-cv-00691-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-12)(Tigan, Jeremy) (Entered: 03/10/2023) (0)
Mar 10, 2023 195 REDACTED VERSION of (296 in 1:21-cv-00691-GBW, 189 in 1:21-cv-01138-GBW, 184 in 1:21-cv-01594-GBW) Letter to The Honorable Gregory B. Williams from Daniel Silver re: Amendment of Infringement Contentions by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 03/10/2023) (30)
Mar 8, 2023 193 ORAL ORDER: Avadel's motion for leave to amend its non-infringement contentions is GRANTED. Avadel's final contentions were due on May 6, 2022. D.I. 72 & 97. Avadel "served its amended non-infringement contentions on February 16 2023 ." D.I. 296-1 at 4; D.I. 296 at 2. As a result, Avadel's motion seeks an alteration to a Scheduling Order deadline, which implicates Fed. R. Civ. P. 16(b)(4). Brit. Telecommunications PLC v. IAC/InterActiveCorp, C.A. No. 18-366-WCB, 2020 WL 3047989, at *2 (D. Del. June 8, 2020). Under Rule 16(b)(4), "[a] schedule may be modified only for good cause and with the judge's consent." "The good cause standard hinges on the diligence of the moving party; in order to show good cause, a movant must first meet the threshold requirement that it demonstrate that, despite diligence, the proposed new filing could not have reasonably been made in a timely manner." Vaxel Int'l Co., Ltd v. HealthCo LLC, C.A. No. 20-224-GBW, D.I. 226 (D. Del. June 28, 2022). The Court also considers "the importance of the new information, evidence of gamesmanship in the untimely disclosure, the potential prejudice to the opposing party, and the likelihood of disruption to the case schedule." Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung e.V. v. Sirus XM Radio Inc., C.A. No. 17-184-JFB-SRF, 2022 WL 608143, at *2 (D. Del. Jan. 27, 2022), report and recommendation adopted and objections overruled, D.I. 563 (May 25, 2022). Here, the Court agrees with Avadel that there is "good cause for the assertion of a non-infringement theory that crystalized only after Jazz served its opening expert reports" because "[u]ntil then, it was not clear that Jazz would accuse sodium oxybate alone of meeting the oxybate limitations." D.I. 296 at 3. After receiving Jazz's opening expert reports on January 17, 2023, D.I. 287, Avadel raised its concerns with Jazz on February 8, D.I. 296-1 at 191-92, and shared its proposed amended non-infringement contentions on February 16, id. at 190. Avadel's amendments appear central to its non-infringement positions and Jazz does not argue gamesmanship. Although Jazz appears to principally complain that responding to Avadel's amendments will require substantial effort that may imperil the trial date, D.I. 298 at 3, any prejudice does not appear incurable. Accordingly, the parties SHALL meet and confer and, no later than March 15, 2023, submit to the Court (a) a stipulated amended Scheduling Order modifying any relevant deadlines necessary for Jazz to address Avadel's amended non-infringement contentions, which modifications shall not disrupt the October 2023 trial date, and (b) the parties shall identify whether the Court must construe "gamma hydroxybutyrate" beyond its plain and ordinary meaning, which is the default in claim construction. Phillips v. AWH Corp., 415 F.3d 1303, 1316 (Fed. Cir. 2005). If the parties are unable to reach agreement on a stipulated amended Scheduling Order or whether "gamma hydroxybutyrate" requires construction, then, on or before March 15, 2023, Jazz shall file a supplemental letter of no more than three (3) pages identifying (a) any dates in the Scheduling Order for which Jazz requests adjustment and (b) its claim construction position on "gamma hydroxybutyrate," including its position on what the plain and ordinary meaning of that term is, if Jazz argues plain and ordinary meaning. Avadel shall file a responsive letter of no more than three (3) pages addressing the same issues no later than March 22, 2022. The teleconference scheduled for March 8, 2023 is CANCELED. ORDERED by Judge Gregory B. Williams. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(etg) (Entered: 03/08/2023) (0)
Mar 7, 2023 192 STIPULATION TO EXTEND TIME for Defendant to submit a redacted public version of its February 28, 2023 Discovery Dispute Letter and supporting exhibits (see C.A. 21-691-GBW, D.I. No. 196) to March 10, 2023 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 03/07/2023) (2)
Mar 3, 2023 191 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Jazz's Opposition to Avadel's Motion to Amend Its Infringement Contentions - re (296 in 1:21-cv-00691-GBW, 189 in 1:21-cv-01138-GBW, 184 in 1:21-cv-01594-GBW) Letter. (Attachments: # 1 Exhibits 1-12)(Tigan, Jeremy) (Entered: 03/03/2023) (0)
Feb 28, 2023 189 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Amendment to Infringement Contentions. (Attachments: # 1 Exhibits A - N, # 2 Certificate of Service)(Silver, Daniel) (Entered: 02/28/2023) (0)
Feb 28, 2023 190 DECLARATION re (296 in 1:21-cv-00691-GBW, 189 in 1:21-cv-01138-GBW, 184 in 1:21-cv-01594-GBW) Letter Declaration of Alexander M. Klibanov, Ph.D. by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) (Entered: 02/28/2023) (3)
Feb 14, 2023 188 ORAL ORDER: IT IS HEREBY ORDERED that a thirty (30) minute discovery teleconference will be held on Wednesday, March 8 at 3:00 p.m. The parties shall arrange for the teleconference and shall provide chambers with the call-in information. IT IS FURTHER ORDERED that, not later than Tuesday, February 28, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than Friday, March 3, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Gregory B. Williams on 2/14/23. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 02/14/2023) (0)
Feb 13, 2023 187 Joint Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding scheduling of a discovery teleconference. (Silver, Daniel) (Entered: 02/13/2023) (1)
Feb 6, 2023 186 REDACTED VERSION of (180 in 1:21-cv-01594-GBW, 185 in 1:21-cv-01138-GBW, 291 in 1:21-cv-00691-GBW) MOTION to Redact (283 in 1:21-cv-00691-GBW) Transcript,, January 4, 2023 Discovery Teleconference Transcript by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Tigan, Jeremy) (Entered: 02/06/2023) (0)
Jan 30, 2023 185 [SEALED] MOTION to Redact (283 in 1:21-cv-00691-GBW) Transcript,, January 4, 2023 Discovery Teleconference Transcript - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Ex. A, # 2 Ex. B)(Tigan, Jeremy) (Entered: 01/30/2023) (0)
Jan 26, 2023 184 STIPULATION TO EXTEND TIME for any party to submit a redaction request related to the transcript of the January 4, 2023 teleconference to January 30, 2023 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy) (Entered: 01/26/2023) (2)
Jan 24, 2023 183 NOTICE requesting Clerk to remove Yi Ning as co-counsel.. (Joyce, Alexandra) (Entered: 01/24/2023) (2)
Jan 18, 2023 181 NOTICE OF SERVICE of (1) Opening Expert Report of Richard K. Bogan Regarding U.S. Patent Nos. 10,959,956, 10,966,931 and 11,077,079, (2) Expert Report of Charles A. Kohl, Ph.D., (3) Opening Expert Report of Steven R. Little, Ph.D., and (4) Expert Report of Edward M. Sellers, M.D., PhD, FRCPC, FACP filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 01/18/2023) (6)
Jan 18, 2023 182 NOTICE OF SERVICE of (1) Opening Expert Report of Bruce Corser, M.D., (2) Opening Expert Report of Kevin C. Almeroth Regarding Patent Ineligibility of U.S. Patent No. 8,731,963, (3) Opening Expert Report of Dr. Cory Berkland, (4) Opening Expert Report of Vivian Gray, (5) Opening Expert Report of Robert S. Langer, (6) Opening Expert Report of Alexander M. Klibanov, Ph.D., (7) Opening Expert Report of William Charman, (8) Opening Expert Report of Dr. Jeffrey Gudin Regarding Invalidity of U.S. Patent 8,731,963, (9) Expert Report of Dr. Martin Scharf, and (10) Opening Expert Report of Joseph Matal filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 01/18/2023) (3)
Jan 6, 2023 180 NOTICE OF SERVICE of (1) Defendant's Responses to Jazz Pharmaceuticals' Fourth Set of Requests for Production of Documents and Things (No. 81) and (2) Avadel's Responses to Plaintiffs' Second Set of Requests for Admission (Nos. 69-72) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 01/06/2023) (3)
Jan 5, 2023 174 REDACTED VERSION of (277 in 1:21-cv-00691-GBW, 172 in 1:21-cv-01138-GBW, 167 in 1:21-cv-01594-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-4)(Tigan, Jeremy) (Entered: 01/05/2023) (0)
Jan 5, 2023 175 REDACTED VERSION of (275 in 1:21-cv-00691-GBW, 170 in 1:21-cv-01138-GBW, 165 in 1:21-cv-01594-GBW) Letter from Daniel M. Silver to the Honorable Gregory B. Williams regarding Discovery Dispute by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/05/2023) (30)
Jan 5, 2023 176 Joint STIPULATION and [Proposed] Order Regarding Deposition Testimony of Philip McGarrigle by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/05/2023) (4)
Jan 5, 2023 177 ORAL ORDER: Jazz's request to stay expert discovery related to the '963 patent is denied. In the Court's discretion, a stay will not simplify the issues for trial because disputes related to the '963 patent remain in this action, and a stay would tactically disadvantage and unduly prejudice Avadel by permitting Jazz to enjoy regulatory exclusivity, which has been contested, without ever having to substantiate the merits of its infringement allegations. IT IS FURTHER ORDERED that, for the reasons stated on the record, Avadel's request for an additional three hours to depose Jazz's Rule 30(b)(6) witness, Clark Allphin, is granted. For topics 9, 11-13, and 17-21, to the extent that Avadel intends to question the witness about specific experiments or documents, Avadel should identify for Jazz the specific experiments or documents for which it intends to seek testimony at least 72 hours prior to the deposition. However, consistent with the additional instructions given by the Court during yesterday's hearing on the record, Avadel is not expected to identify for Jazz prior to the deposition questions seeking general information about specific topics for example, whether any experiment was conducted on a specific topic. ORDERED by Judge Gregory B. Williams on 1/5/23. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) Modified on 1/5/2023 (ntl). (Entered: 01/05/2023) (0)
Jan 5, 2023 178 NOTICE of Change of Firm Affiliation by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC (Joyce, Alexandra) (Entered: 01/05/2023) (3)
Jan 5, 2023 179 REDACTED VERSION of (173 in 1:21-cv-01138-GBW, 168 in 1:21-cv-01594-GBW, 278 in 1:21-cv-00691-GBW) Letter, from Daniel M. Silver to The Honorable Gregory B. Williams in Opposition to Jazz's Request to Stay Expert Discovery Related to the '963 Patent by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 01/05/2023) (7)
Dec 29, 2022 172 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Opposition to Avadel's December 27, 2022 Discovery Dispute Letter - re (275 in 1:21-cv-00691-GBW, 170 in 1:21-cv-01138-GBW, 165 in 1:21-cv-01594-GBW) Letter. (Attachments: # 1 Exs. 1-4)(Tigan, Jeremy) (Entered: 12/29/2022) (0)
Dec 29, 2022 173 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Opposition to Jazz's Request to Stay Expert Discovery Related to the '963 Patent - re (166 in 1:21-cv-01594-GBW, 276 in 1:21-cv-00691-GBW, 171 in 1:21-cv-01138-GBW) Letter. (Attachments: # 1 Exhibit 1, # 2 Certificate of Service)(Silver, Daniel) (Entered: 12/29/2022) (0)
Dec 27, 2022 170 [SEALED] Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Discovery Dispute. (Attachments: # 1 Exhibits A-H, # 2 Certificate of Service)(Silver, Daniel) (Entered: 12/27/2022) (0)
Dec 27, 2022 171 Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Jazz's Request to Stay Expert Discovery Related to the '963 Patent. (Attachments: # 1 Exs. A-B)(Tigan, Jeremy) (Entered: 12/27/2022) (0)
Dec 22, 2022 167 Letter to Honorable Gregory B. Williams from Jeremy A. Tigan regarding scheduling of a discovery teleconference. (Tigan, Jeremy) (Entered: 12/22/2022) (2)
Dec 22, 2022 168 REDACTED VERSION of (266 in 1:21-cv-00691-GBW, 156 in 1:21-cv-01594-GBW, 161 in 1:21-cv-01138-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Tigan, Jeremy) (Entered: 12/22/2022) (0)
Dec 22, 2022 169 ORAL ORDER: IT IS HEREBY ORDERED that the dispute identified in D.I. 272 in C.A. No. 21-691-GBW, D.I. 167 in C.A. No. 21-1138-GBW, and D.I. 162 in C.A. No. 21-1594-GBW will also be heard during the January 4, 2023 discovery teleconference. The parties shall submit their respective letter briefs pursuant to the briefing schedule previously ordered by the Court. ORDERED by Judge Gregory B. Williams on 12/22/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 12/22/2022) (0)
Dec 21, 2022 166 ORAL ORDER: IT IS HEREBY ORDERED that a thirty (30) minute discovery teleconference will be held on January 4, 2023 at 11:00 a.m. The parties shall arrange for the teleconference and shall provide chambers with the call-in information. IT IS FURTHER ORDERED that, not later than Tuesday, December 27, 2022, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than Thursday, December 29, 2022, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Gregory B. Williams on 12/21/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 12/21/2022) (0)
Dec 19, 2022 163 Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding Request for Discovery Teleconference. (Silver, Daniel) (Entered: 12/19/2022) (2)
Dec 19, 2022 164 STIPULATION AND ORDER TO MODIFY SCHEDULING ORDER. Signed by Judge Gregory B. Williams on 12/19/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 12/19/2022) (2)
Dec 19, 2022 165 REDACTED PUBLIC VERSION of 157 Memorandum Order. (ntl) (Entered: 12/19/2022) (14)
Dec 15, 2022 162 NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for Admission to Defendant Avadel CNS Pharmaceuticals (Nos. 69-72) and (2) Plaintiffs' Fourth Set of Requests for the Production of Documents and Things (No. 81) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/15/2022) (5)
Dec 14, 2022 161 [SEALED] Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Response to the Court's December 8, 2022 Memorandum Order - re (260 in 1:21-cv-00691-GBW, 157 in 1:21-cv-01138-GBW, 152 in 1:21-cv-01594-GBW) Memorandum and Order,,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Tigan, Jeremy) (Entered: 12/14/2022) (0)
Dec 13, 2022 160 NOTICE OF SERVICE of Jazz Pharmaceuticals' Third Amended Initial Disclosures filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/13/2022) (5)
Dec 9, 2022 159 NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections and Responses to Defendant's Sixth & Seventh Sets of Interrogatories (Nos. 19-21) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy) (Entered: 12/09/2022) (5)
Dec 8, 2022 157 [SEALED] MEMORANDUM ORDER re (175 in 1:21-cv-00691-GBW, 105 in 1:21-cv-01594-GBW, 110 in 1:21-cv-01138-GBW) MOTION to Strike Avadel's Second Supplemental Response to Interrogatory No. 8 filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. is GRANTED-IN-PART and DENIED-IN-PART. Signed by Judge Gregory B. Williams on 12/8/22. This document has been emailed to local counsel. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 12/08/2022) (0)
Dec 8, 2022 158 MOTION for Pro Hac Vice Appearance of Attorney Rose S. Lee - filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. (Joyce, Alexandra) (Entered: 12/08/2022) (3)
Nov 30, 2022 156 NOTICE to Take Deposition of Jed Black on December 2, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel) (Entered: 11/30/2022) (2)
Nov 29, 2022 155 Letter to The Honorable Gregory B. Williams from Daniel M.Silver regarding Court of Appeals to the Federal Circuit Order. (Attachments: # 1 Enclosure)(Silver, Daniel) (Entered: 11/29/2022) (Main Document) (1)
Nov 29, 2022 155 Letter to The Honorable Gregory B. Williams from Daniel M.Silver regarding Court of Appeals to the Federal Circuit Order. (Attachments: # 1 Enclosure)(Silver, Daniel) (Entered: 11/29/2022) (Enclosure) (2)
Nov 28, 2022 154 STIPULATION TO EXTEND TIME (1) Opening Expert Reports, (2) Rebuttal Expert Reports, (3) Reply Expert Reports, and (4) Expert Discovery Cutoff to (1) January 17, 2023, (2) March 17, 2023, (3) May 15, 2023, and (4) June 30, 2023 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) (Entered: 11/28/2022) (3)
Nov 21, 2022 153 NOTICE OF SERVICE of Defendant Avadel CNS Pharmaceuticals, LLC's Amended Initial Disclosures Pursuant to Fed. R. Civ. P 26(a) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 11/21/2022) (3)
Nov 18, 2022 151 MEMORANDUM OPINION re claim construction. Signed by Judge Gregory B. Williams on 11/18/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 11/18/2022) (22)
Nov 18, 2022 152 ORDER re (151 in 1:21-cv-01138-GBW, 146 in 1:21-cv-01594-GBW, 229 in 1:21-cv-00691-GBW) Memorandum Opinion regarding claim construction. Signed by Judge Gregory B. Williams on 11/18/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl) (Entered: 11/18/2022) (3)
Nov 17, 2022 150 NOTICE OF SERVICE of Amended Notice of Third-Party Deposition Subpoena to Cooley LLP filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra) (Entered: 11/17/2022) (3)
Nov 9, 2022 149 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Sherice Mills on November 11, 2022 filed by Avadel CNS Pharmaceuticals LLC.(Silver, Daniel)
Nov 7, 2022 148 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Diana Pohle on November 9, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Nov 4, 2022 147 Letter (Main Document) (1)
Docket Text: Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding APA Decision. (Attachments: # (1) Decision C.A. No. 22-2159 (D.D.C.))(Silver, Daniel)
Nov 4, 2022 147 Letter (Decision C.A. No. 22-2159 (D.D.C.)) (17)
Docket Text: Letter to The Honorable Gregory B. Williams from Daniel M. Silver regarding APA Decision. (Attachments: # (1) Decision C.A. No. 22-2159 (D.D.C.))(Silver, Daniel)
Nov 3, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (216 in 1:21-cv-00691-GBW, 145 in 1:21-cv-01138-GBW, 140 in 1:21-cv-01594-GBW) MOTION for Pro Hac Vice Appearance of Attorney Quentin Jorgensen filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 11/3/2022. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW(etg)
Nov 3, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Franco Benyamin for Avadel CNS Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)
Nov 2, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (214 in 1:21-cv-00691-GBW, 17 in 1:22-cv-00941-GBW, 36 in 1:22-cv-00487-GBW, 138 in 1:21-cv-01594-GBW, 143 in 1:21-cv-01138-GBW) MOTION for Pro Hac Vice Appearance of Attorney Eric P. Berger, Rebecca E. Weires, and Andrew T. Jones filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC, Avadel Pharmaceuticals plc. Signed by Judge Gregory B. Williams on 11/2/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00487-GBW, 1:22-cv-00941-GBW (ntl)
Nov 2, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Rebecca E. Weires and Alan Devlin for Avadel CNS Pharmaceuticals LLC and Avadel Pharmaceuticals PLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-00487-GBW, 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00941-GBW(mpb)
Nov 2, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Andrew T. Jones for Avadel CNS Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)
Nov 2, 2022 145 Motion for Leave to Appear Pro Hac Vice (5)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Quentin Jorgensen - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Nov 2, 2022 146 Notice of Service (Main Document) (3)
Docket Text: NOTICE OF SERVICE of Third-Party Subpoenas to Ian Wilding filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # (1) Subpoena to Produce Documents Directed to Ian Wilding, # (2) Subpoena to Testify Directed to Ian Wilding)(Silver, Daniel)
Nov 2, 2022 146 Notice of Service (Subpoena to Produce Documents Directed to Ian Wilding) (30)
Docket Text: NOTICE OF SERVICE of Third-Party Subpoenas to Ian Wilding filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # (1) Subpoena to Produce Documents Directed to Ian Wilding, # (2) Subpoena to Testify Directed to Ian Wilding)(Silver, Daniel)
Nov 2, 2022 146 Notice of Service (Subpoena to Testify Directed to Ian Wilding) (3)
Docket Text: NOTICE OF SERVICE of Third-Party Subpoenas to Ian Wilding filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # (1) Subpoena to Produce Documents Directed to Ian Wilding, # (2) Subpoena to Testify Directed to Ian Wilding)(Silver, Daniel)
Nov 1, 2022 143 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric P. Berger, Rebecca E. Weires, and Andrew T. Jones - filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC. (Joyce, Alexandra)
Nov 1, 2022 144 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Scott Bura on November 2, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Oct 31, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (16 in 1:22-cv-00941-GBW, 35 in 1:22-cv-00487-GBW, 136 in 1:21-cv-01594-GBW, 141 in 1:21-cv-01138-GBW, 211 in 1:21-cv-00691-GBW) MOTION for Pro Hac Vice Appearance of Attorney Alan Devlin and Ian Conner filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC, Avadel Pharmaceuticals plc. Signed by Judge Gregory B. Williams on 10/31/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00487-GBW, 1:22-cv-00941-GBW (ntl)
Oct 28, 2022 141 Motion for Leave to Appear Pro Hac Vice (5)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alan Devlin and Ian Conner - filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC. (Joyce, Alexandra)
Oct 28, 2022 142 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Avadel's Responses to Plaintiff's First Set of Requests for Admission (Nos. 1-68) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Oct 26, 2022 138 Redacted Document (9)
Docket Text: REDACTED VERSION of (200 in 1:21-cv-00691-GBW, 126 in 1:21-cv-01594-GBW, 131 in 1:21-cv-01138-GBW) Letter to the Honorable Gregory B. Williams in Opposition to Plaintiff's Motion to Compel Damages Discovery by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel)
Oct 26, 2022 139 Redacted Document (Main Document) (4)
Docket Text: REDACTED VERSION of (194 in 1:21-cv-00691-GBW, 120 in 1:21-cv-01594-GBW, 125 in 1:21-cv-01138-GBW) Letter by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Exs. A-F)(Tigan, Jeremy)
Oct 26, 2022 139 Redacted Document (Exs. A-F) (30)
Docket Text: REDACTED VERSION of (194 in 1:21-cv-00691-GBW, 120 in 1:21-cv-01594-GBW, 125 in 1:21-cv-01138-GBW) Letter by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Exs. A-F)(Tigan, Jeremy)
Oct 26, 2022 140 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Edwin Walsh on October 28, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Oct 25, 2022 N/A Markman Hearing (0)
Docket Text: Minute Entry for proceedings held before Judge Gregory B. Williams - Markman Hearing held on 10/25/2022. (Court Reporter M. Rolfe.) Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl)
Oct 21, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (133 in 1:21-cv-01138-GBW, 34 in 1:22-cv-00487-GBW, 202 in 1:21-cv-00691-GBW, 13 in 1:22-cv-00941-GBW, 128 in 1:21-cv-01594-GBW) MOTION for Pro Hac Vice Appearance of Attorney Franco Benyamin filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC, Avadel Pharmaceuticals plc. Signed by Judge Gregory B. Williams on 10/20/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00487-GBW, 1:22-cv-00941-GBW (ntl)
Oct 21, 2022 N/A Order (0)
Docket Text: ORAL ORDER: Upon consideration of the parties' submissions (D.I. 194 & 200) and argument presented to the Court during the hearing on October 20, 2022, Jazz's motion to compel Avadel to produce damages-related discovery in response to Jazz's Requests for Production Nos. 57, 59-64, 68-75, 77-80 is DENIED with leave to renew at the time Avadel commercially manufactures, uses, offers to sell, or sells its NDA Product. ORDERED by Judge Gregory B. Williams on 10/21/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl)
Oct 21, 2022 136 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Seventh Set of Interrogatories (No. 21) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Oct 21, 2022 137 Notice to Take Deposition (Main Document) (2)
Docket Text: NOTICE to Take Deposition of Mark G. Eller on November 15, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A - Subpoena)(Silver, Daniel)
Oct 21, 2022 137 Notice to Take Deposition (Exhibit A - Subpoena) (4)
Docket Text: NOTICE to Take Deposition of Mark G. Eller on November 15, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A - Subpoena)(Silver, Daniel)
Oct 20, 2022 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Gregory B. Williams - Telephone Conference held on 10/20/2022. (Court Reporter M. Rolfe.) Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl)
Oct 20, 2022 133 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Franco Benyamin - filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC. (Joyce, Alexandra)
Oct 20, 2022 134 Redacted Document (Main Document) (1)
Docket Text: REDACTED VERSION of (199 in 1:21-cv-00691-GBW, 125 in 1:21-cv-01594-GBW, 130 in 1:21-cv-01138-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Transcript)(Tigan, Jeremy)
Oct 20, 2022 134 Redacted Document (Transcript) (30)
Docket Text: REDACTED VERSION of (199 in 1:21-cv-00691-GBW, 125 in 1:21-cv-01594-GBW, 130 in 1:21-cv-01138-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Transcript)(Tigan, Jeremy)
Oct 19, 2022 132 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Jazz Pharmaceuticals' Second Amended Initial Disclosures filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Oct 18, 2022 129 Letter (1)
Docket Text: Joint Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Request for Teleconference - re (175 in 1:21-cv-00691-GBW, 105 in 1:21-cv-01594-GBW, 110 in 1:21-cv-01138-GBW) MOTION to Strike Avadel's Second Supplemental Response to Interrogatory No. 8 . (Tigan, Jeremy)
Oct 17, 2022 126 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of John Miller on October 18, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Oct 17, 2022 127 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Clark Allphin on October 21, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Oct 17, 2022 128 Letter (1)
Docket Text: Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding the Court's September 21, 2022 Oral Order - re (179 in 1:21-cv-00691-GBW, 179 in 1:21-cv-00691-GBW) Order,,,,,, Set Hearings,,,,,. (Tigan, Jeremy)
Oct 13, 2022 124 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Jazz Pharmaceuticals' Amended Initial Disclosures filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Oct 12, 2022 123 Redacted Document (30)
Docket Text: REDACTED VERSION of (115 in 1:21-cv-01594-GBW, 120 in 1:21-cv-01138-GBW, 189 in 1:21-cv-00691-GBW) Letter, to The Honorable Gregory B. Williams in Opposition to Plaintiffs' Motion to Strike Defendant's Second Supplemental Response to Interrogatory No. 8 by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel)
Oct 11, 2022 122 Letter (4)
Docket Text: Letter to The Honorable Gregory B. Williams from Jeremy A. Tigan regarding Plaintiffs' Motion to Strike Defendant's Second Supplemental Response to Interrogatory No. 8 - re (115 in 1:21-cv-01594-GBW, 120 in 1:21-cv-01138-GBW, 189 in 1:21-cv-00691-GBW) Letter,. (Tigan, Jeremy)
Oct 5, 2022 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that a thirty (30) minute discovery teleconference will be held on Thursday, October 20, 2022 at 3:00 p.m. The parties shall arrange for the teleconference and shall provide chambers with the call-in information. IT IS FURTHER ORDERED that, not later than Monday, October 17, 2022, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than Tuesday, October 18, 2022, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Gregory B. Williams on 10/5/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl)
Oct 4, 2022 119 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of a witness from Express Scripts on October 5, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Sep 30, 2022 118 Letter (2)
Docket Text: Joint Letter to The Honorable Gregory B. Williams regarding Request for Discovery Dispute Teleconference. (Tigan, Jeremy)
Sep 28, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (115 in 1:21-cv-01138-GBW, 184 in 1:21-cv-00691-GBW, 110 in 1:21-cv-01594-GBW) STIPULATION TO EXTEND TIME 1) Defendant's deadline to file its responsive letter to Plaintiffs' Motion to Strike, and 2) Plaintiffs' deadline to file a reply letter to their Motion to Strike to 1) October 4, 2022, and 2) October 11, 202 filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. Signed by Judge Gregory B. Williams on 9/28/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW (ntl)
Sep 28, 2022 117 Redacted Document (Main Document) (4)
Docket Text: REDACTED VERSION of (176 in 1:21-cv-00691-GBW, 106 in 1:21-cv-01594-GBW, 111 in 1:21-cv-01138-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-E)(Tigan, Jeremy)
Sep 28, 2022 117 Redacted Document (Exhibits A-E) (30)
Docket Text: REDACTED VERSION of (176 in 1:21-cv-00691-GBW, 106 in 1:21-cv-01594-GBW, 111 in 1:21-cv-01138-GBW) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-E)(Tigan, Jeremy)
Sep 27, 2022 116 Notice (Other) (30)
Docket Text: NOTICE of Subpoena Ad Testificandum to Express Scripts, Inc. by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Tigan, Jeremy)
Sep 23, 2022 115 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME 1) Defendant's deadline to file its responsive letter to Plaintiffs' Motion to Strike, and 2) Plaintiffs' deadline to file a reply letter to their Motion to Strike to 1) October 4, 2022, and 2) October 11, 2022 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra)
Sep 22, 2022 113 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendants Seventh Set of Interrogatories to Plaintiffs Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Ltd filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Sep 22, 2022 114 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Sixth Set of Interrogatories (Nos. 18-20) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Sep 21, 2022 112 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission to Defendant Avadel CNS Pharmaceuticals (Nos. 1-68) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Sep 20, 2022 110 Motion for Miscellaneous Relief (7)
Docket Text: MOTION to Strike Avadel's Second Supplemental Response to Interrogatory No. 8 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Sep 16, 2022 109 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Avadel CNS Pharmaceuticals, LLC's Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Sep 15, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (108 in 1:21-cv-01138-GBW, 164 in 1:21-cv-00691-GBW, 7 in 1:22-cv-00941-GBW, 103 in 1:21-cv-01594-GBW) MOTION for Pro Hac Vice Appearance of Attorney Krista M. Rycroft filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 9/14/22. Associated Cases: 1:21-cv-00691-GBW, 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00941-GBW (ntl)
Sep 13, 2022 108 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Krista M. Rycroft - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Sep 12, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (102 in 1:21-cv-01594-GBW, 6 in 1:22-cv-00941-GBW, 107 in 1:21-cv-01138-GBW) MOTION for Pro Hac Vice Appearance of Attorney F. Dominic Cerrito, Eric C. Stops, Evangeline Shih, Andrew S. Chalson, Gabriel P. Brier, Frank C. Calvosa and Nicholas LoCastro filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. Signed by Judge Gregory B. Williams on 9/9/22. Associated Cases: 1:21-cv-01138-GBW, 1:21-cv-01594-GBW, 1:22-cv-00941-GBW (ntl)
Sep 9, 2022 107 Motion for Leave to Appear Pro Hac Vice (11)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney F. Dominic Cerrito, Eric C. Stops, Evangeline Shih, Andrew S. Chalson, Gabriel P. Brier, Frank C. Calvosa and Nicholas LoCastro - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Sep 7, 2022 N/A Case Assigned/Reassigned (0)
Docket Text: Case Reassigned to Judge Gregory B Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. Associated Cases: 1:21-cv-00691-MN, 1:21-cv-01138-MN, 1:21-cv-01594-MN, 1:22-cv-00487-MN(apk)
Sep 2, 2022 106 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Avadel's Second Supplemental Responses to Jazz Pharmaceuticals, Inc.s First Set of Interrogatories (No. 8) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Aug 31, 2022 105 Redacted Document (3)
Docket Text: REDACTED VERSION of (97 in 1:21-cv-01594-MN, 150 in 1:21-cv-00691-MN, 102 in 1:21-cv-01138-MN) Letter, by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra)
Aug 30, 2022 104 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant's Notice of Deposition of Plaintiff Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Ltd. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Aug 25, 2022 103 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant's Responses and Objections to Plaintiffs' Notice of Deposition to Avadel CNS Pharmaceuticals, LLC Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Aug 24, 2022 101 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Subpoenas filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Aug 23, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that the 8/31/2022 2:00 PM Markman hearing is POSTPONED to a date to be determined. ORDERED by Judge Maryellen Noreika on 8/23/2022. (dlw)
Aug 23, 2022 99 Notice of Change of Address (3)
Docket Text: NOTICE of Change of Address by Alexandra M. Joyce (Joyce, Alexandra)
Aug 23, 2022 100 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant's Sixth Set of Interrogatories to Plaintiffs Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Ltd. filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra)
Aug 19, 2022 97 Claim Construction Chart (Main Document) (10)
Docket Text: AMENDED JOINT CLAIM Construction Chart by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Letter to The Honorable Maryellen Noreika)(Tigan, Jeremy) Modified on 8/19/2022 (dlw).
Aug 19, 2022 97 Claim Construction Chart (Letter to The Honorable Maryellen Noreika) (1)
Docket Text: AMENDED JOINT CLAIM Construction Chart by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Letter to The Honorable Maryellen Noreika)(Tigan, Jeremy) Modified on 8/19/2022 (dlw).
Aug 15, 2022 96 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Seventh Set of Requests for the Production of Documents and Things (Nos. 100-106) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Aug 11, 2022 92 Notice of Service (6)
Docket Text: NOTICE OF SERVICE of Third-Party Subpoena and Notice of Deposition of Michael Desjardin filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Aug 11, 2022 93 Notice to Take Deposition (2)
Docket Text: NOTICE to Take Deposition of Jed Black on August 23, 2022 filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Aug 11, 2022 94 Notice (Other) (Main Document) (4)
Docket Text: NOTICE of Subpoena Ad Testificandum to David Monteith by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Exhibit 1)(Tigan, Jeremy)
Aug 11, 2022 94 Notice (Other) (Exhibit 1) (4)
Docket Text: NOTICE of Subpoena Ad Testificandum to David Monteith by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Exhibit 1)(Tigan, Jeremy)
Aug 11, 2022 95 Notice (Other) (Main Document) (4)
Docket Text: NOTICE of Subpoena Ad Testificandum to Thorsteinn Thorsteinsson by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Exhibit 1)(Tigan, Jeremy)
Aug 11, 2022 95 Notice (Other) (Exhibit 1) (4)
Docket Text: NOTICE of Subpoena Ad Testificandum to Thorsteinn Thorsteinsson by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Exhibit 1)(Tigan, Jeremy)
Aug 10, 2022 91 Letter (2)
Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver, Esq. regarding Avadel's Reponse to Jazz's August 9, 2022 Letter Regarding D.C. District Court Action - re (138 in 1:21-cv-00691-MN) Letter. (Silver, Daniel)
Aug 9, 2022 90 Letter (2)
Docket Text: Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding update on related actions. (Tigan, Jeremy)
Aug 8, 2022 89 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(1) and (2) Plaintiffs' Notice of Deposition to Avadel CNS Pharmaceuticals, LLC Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Aug 1, 2022 86 Letter (1)
Docket Text: Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding August 31, 2022 Markman hearing. (Tigan, Jeremy)
Aug 1, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER re (78 in 1:21-cv-01594-MN) (84 in 1:21-cv-01138-MN) (132 in 1:21-cv-00691-MN) Joint Claim Construction Brief - IT IS HEREBY ORDERED that, on or before 8/24/2022, local and lead counsel (i.e., those attorneys that will be leading trial) for the parties shall meet and confer and file an amended joint claim construction chart that sets forth the terms that remain in dispute. The meet and confer shall focus on an attempt to reach agreement on any remaining disputed terms where possible and on an attempt to focus the dispute over the remaining terms in light of the joint claim construction brief. Accompanying any amended joint claim construction chart, the parties shall file a letter with the Court identifying by name each individual who participated in the meet and confer, when and how that meet and confer occurred and how long it lasted. If no agreements on constructions have been reached or if no dispute has been narrowed on the meet and confer, the letter shall so state and the parties need not file an amended joint claim construction chart. ORDERED by Judge Maryellen Noreika on 8/1/2022. (dlw)
Aug 1, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER re (86 in 1:21-cv-01138-MN, 80 in 1:21-cv-01594-MN, 134 in 1:21-cv-00691-MN) Letter - IT IS HEREBY ORDERED that the Court is setting aside two (2) hours for the Markman hearing with the time split equally between the two sides. Any slide presentations the parties wish to use during the hearing shall be emailed (in PDF format) to MN_civil@ded.uscourts.gov no later than 24 hours prior to the hearing with hard copies delivered to the Clerk's office within one hour thereafter. The parties may, however, agree upon a different time to exchange their respective slides. ORDERED by Judge Maryellen Noreika on 8/1/2022. (dlw)
Jul 29, 2022 83 Letter (1)
Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver, Esq. regarding Technology Tutorial. (Silver, Daniel)
Jul 29, 2022 84 Joint Claim Construction Brief (30)
Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Tigan, Jeremy)
Jul 29, 2022 85 Appendix (Main Document) (5)
Docket Text: Joint Claim Construction APPENDIX re (78 in 1:21-cv-01594-MN) Joint Claim Construction Brief, (84 in 1:21-cv-01138-MN) Joint Claim Construction Brief, (132 in 1:21-cv-00691-MN) Joint Claim Construction Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Exhibits 1-17 and A-U)(Tigan, Jeremy) Modified on 8/1/2022 (dlw).
Jul 29, 2022 85 Appendix (Exhibits 1-17 and A-U) (30)
Docket Text: Joint Claim Construction APPENDIX re (78 in 1:21-cv-01594-MN) Joint Claim Construction Brief, (84 in 1:21-cv-01138-MN) Joint Claim Construction Brief, (132 in 1:21-cv-00691-MN) Joint Claim Construction Brief by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Attachments: # (1) Exhibits 1-17 and A-U)(Tigan, Jeremy) Modified on 8/1/2022 (dlw).
Jul 25, 2022 82 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Avadel CNS Pharmaceuticals, LLC's Sur-Reply Claim Construction Brief and supporting exhibits filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Jul 18, 2022 81 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant's Responses to Jazz Pharmaceuticals' Third Set of Requests for Production of Documents and Things (Nos. 57-80) filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Jul 14, 2022 80 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant's Seventh Set of Requests for Production of Documents and Things to Plaintiffs Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Ltd. filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Jul 8, 2022 79 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Responsive Markman Brief filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Jul 7, 2022 78 Objections (Main Document) (7)
Docket Text: OBJECTIONS by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. to (117 in 1:21-cv-00691-MN) MOTION for Judgment on the Pleadings (Renewed) . (Attachments: # (1) Exhibits A-D)(Tigan, Jeremy)
Jul 7, 2022 78 Objections (Exhibits A-D) (21)
Docket Text: OBJECTIONS by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. to (117 in 1:21-cv-00691-MN) MOTION for Judgment on the Pleadings (Renewed) . (Attachments: # (1) Exhibits A-D)(Tigan, Jeremy)
Jul 5, 2022 76 Notice Requesting Removal of Co-Counsel (3)
Docket Text: NOTICE requesting Clerk to remove Rashmi Borah as co-counsel.. (Joyce, Alexandra)
Jul 5, 2022 77 Redacted Document (2)
Docket Text: REDACTED VERSION of (120 in 1:21-cv-00691-MN, 69 in 1:21-cv-01594-MN, 75 in 1:21-cv-01138-MN) Letter, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Jun 20, 2022 74 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Avadel CNS Pharmaceuticals, LLC's Answering Claim Construction Brief filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Jun 17, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Audra Sawyer for Avadel CNS Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
Jun 17, 2022 73 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Jazz Pharmaceuticals' Third Set of Requests for the Production of Documents and Things (Nos. 57-80) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Jun 15, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re (72 in 1:21-cv-01138-MN, 20 in 1:22-cv-00487-MN, 114 in 1:21-cv-00691-MN, 66 in 1:21-cv-01594-MN) MOTION for Pro Hac Vice Appearance of Attorney Audra Sawyer filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC, Avadel Pharmaceuticals plc. ORDERED by Judge Maryellen Noreika on 6/15/2022. (dlw)
Jun 15, 2022 72 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Audra Sawyer - filed by Avadel CNS Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC. (Joyce, Alexandra)
Jun 6, 2022 71 Letter (1)
Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver regarding withdrawing claim construction dispute. (Silver, Daniel)
May 27, 2022 70 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Markman Brief filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
May 13, 2022 66 Letter (2)
Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver regarding Claim Construction Dispute - re (65 in 1:21-cv-01138-MN, 59 in 1:21-cv-01594-MN, 106 in 1:21-cv-00691-MN) Letter. (Silver, Daniel)
May 13, 2022 67 Letter (2)
Docket Text: Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding response to Avadel's letter - re (60 in 1:21-cv-01594-MN, 107 in 1:21-cv-00691-MN, 66 in 1:21-cv-01138-MN) Letter. (Tigan, Jeremy)
May 13, 2022 68 Claim Construction Chart (6)
Docket Text: SUPPLEMENTAL CLAIM Construction Chart by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra) Modified on 5/16/2022 (dlw).
May 13, 2022 69 Claim Construction Chart (10)
Docket Text: JOINT CLAIM Construction Chart by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. (Tigan, Jeremy) Modified on 5/16/2022 (dlw).
May 12, 2022 65 Letter (2)
Docket Text: Letter to The Honorable Maryellen Noreika from Jeremy A. Tigan regarding Claim Construction Dispute. (Tigan, Jeremy)
May 9, 2022 63 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant Avadel CNS Pharmaceuticals, LLC's Final Invalidity Contentions filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
May 9, 2022 64 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Final Infringement Contentions filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
May 4, 2022 62 Redacted Document (30)
Docket Text: REDACTED VERSION of (100 in 1:21-cv-00691-MN, 53 in 1:21-cv-01594-MN, 59 in 1:21-cv-01138-MN) Joint MOTION to Redact Limited Portions of the April 6, 2022 Teleconference Transcript by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra)
Apr 29, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re (100 in 1:21-cv-00691-MN, 53 in 1:21-cv-01594-MN, 59 in 1:21-cv-01138-MN) Joint MOTION to Redact Limited Portions of the April 6, 2022 Teleconference Transcript. ORDERED by Judge Maryellen Noreika on 4/29/2022. (dlw)
Apr 29, 2022 61 Redacted Document (8)
Docket Text: REDACTED VERSION of (101 in 1:21-cv-00691-MN) Transcript, (60 in 1:21-cv-01138-MN) Transcript, (54 in 1:21-cv-01594-MN) Transcript. (dlw)
Apr 27, 2022 58 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of Third Party Subpoenas to Express Scripts, Inc. to (1) Testify at Deposition, and (2) Produce Documents, Information, or Objects or to Permit Inspection of Presmises filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Apr 21, 2022 57 Notice (Other) (2)
Docket Text: NOTICE of Withdrawal of Angela C. Whitesell as Counsel by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC (Whitesell, Angela)
Apr 19, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re (97 in 1:21-cv-00691-MN, 50 in 1:21-cv-01594-MN, 56 in 1:21-cv-01138-MN) STIPULATION TO EXTEND TIME for Plaintiffs to serve final infringement contentions and Defendant to serve final invalidity contentions to May 6, 2022. ORDERED by Judge Maryellen Noreika on 4/19/2022. (dlw)
Apr 19, 2022 56 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for Plaintiffs to serve final infringement contentions and Defendant to serve final invalidity contentions to May 6, 2022 - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra)
Apr 11, 2022 N/A Case No Longer Referred to Mediation (0)
Docket Text: CASE NO LONGER REFERRED to Magistrate Judge Hall for the purpose of exploring ADR. Please see the Court's Standing Order No. 2022-2 dated March 14, 2022. (ceg)
Apr 7, 2022 55 SO ORDERED (4)
Docket Text: SO ORDERED re (48 in 1:21-cv-01594-MN, 95 in 1:21-cv-00691-MN, 54 in 1:21-cv-01138-MN) Stipulation and Order Regarding Protective Order Modification. Signed by Judge Maryellen Noreika on 4/7/2022. (dlw)
Apr 6, 2022 N/A Telephone Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Maryellen Noreika - Telephone Conference held on 4/6/2022 re Stipulation and Proposed Order Regarding Potential Preliminary Injunction Proceedings. The stipulation is DENIED as unnecessary. If a motion for a preliminary injunction is filed, the deadlines of the briefing will follow the Local Rules of this Court. (Court Reporter Dale Hawkins.) Associated Cases: 1:21-cv-00691-MN, 1:21-cv-01138-MN, 1:21-cv-01594-MN(mdb)
Apr 6, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: For the reasons stated on the April 6, 2022 telephone conference, the Stipulation and Proposed Order Regarding Potential Preliminary Injunction Proceedings (41 in 1:21-cv-01594-MN, 47 in 1:21-cv-01138-MN, 88 in 1:21-cv-00691-MN) is DENIED. ORDERED by Judge Maryellen Noreika on 4/6/2022. Associated Cases: 1:21-cv-00691-MN, 1:21-cv-01138-MN, 1:21-cv-01594-MN(mdb)
Apr 6, 2022 54 Stipulation (4)
Docket Text: STIPULATION and [Proposed] Order Regarding Protective Order Modification by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel)
Apr 4, 2022 52 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant Avadel CNS Pharmaceuticals, LLC's Final Non-Infringement Contentions filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Whitesell, Angela)
Apr 1, 2022 49 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by Angela Whitesell on behalf of Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC (Whitesell, Angela)
Apr 1, 2022 50 Redacted Document (5)
Docket Text: REDACTED VERSION of (41 in 1:21-cv-01594-MN, 47 in 1:21-cv-01138-MN, 88 in 1:21-cv-00691-MN) Stipulation and [Proposed] Order Regarding Potential Preliminary Injunction Motion by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel) Modified on 4/4/2022 (mdb).
Apr 1, 2022 51 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiff's Responses to Defendants' Validity Contentions filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Mar 29, 2022 N/A Order Setting Teleconference (0)
Docket Text: ORAL ORDER Setting Teleconference re Stipulation and [Proposed] Order Regarding Potential Preliminary Injunction Motion - IT IS HEREBY ORDERED that a Telephone Conference is set for 4/6/2022 at 10:00 AM before Judge Maryellen Noreika. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 3/29/2022. (dlw)
Mar 18, 2022 46 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant's Fifth Set of Interrogatories (No. 17) and (2) Plaintiffs' Objections and Responses to Defendant's Sixth Set of Requests for the Production of Documents and Things (Nos. 76-99) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Mar 7, 2022 45 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant Avadel CNS Pharmaceuticals, LLC's Preliminary Proposed Claim Constructions filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Joyce, Alexandra)
Mar 1, 2022 44 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendant's Fifth Set of Requests for Production of Documents and Things (Nos. 42-75); (2) Plaintiffs' Objections and Responses to Defendant's Fourth Set of Interrogatories (Nos. 14-16);(3) Plaintiffs' Objections and Responses to Defendant's First Set of Requests for Admission (Nos. 1-16) filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Feb 25, 2022 43 Answer to Counterclaim (Main Document) (30)
Docket Text: Amended ANSWER to [12] Answer to Complaint,, Counterclaim, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-F)(Tigan, Jeremy)
Feb 25, 2022 43 Answer to Counterclaim (Exhibits A-F) (30)
Docket Text: Amended ANSWER to [12] Answer to Complaint,, Counterclaim, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-F)(Tigan, Jeremy)
Feb 24, 2022 41 Stipulation (2)
Docket Text: STIPULATION and [Proposed] Order to Amend Answers by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Feb 24, 2022 42 SO ORDERED (2)
Docket Text: SO ORDERED re (41 in 1:21-cv-01138-MN, 34 in 1:21-cv-01594-MN, 81 in 1:21-cv-00691-MN) Stipulation and Order to Amend Answers. Signed by Judge Maryellen Noreika on 2/24/2022. (dlw)
Feb 22, 2022 40 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant Avadel CNS Pharamceuticals, LLC's Identification of Claim Terms for Construction filed by Avadel CNS Pharmaceuticals LLC.(Silver, Daniel)
Feb 16, 2022 39 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of (1) Defendant's Fifth Set of Interrogatories to Plaintiffs and (2) Defendant's Sixth Set of Requests for Production of Documents and Things to Plaintiff filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC.(Silver, Daniel)
Jan 27, 2022 38 Notice of Service (4)
Docket Text: NOTICE OF SERVICE of (1) Defendant's First Set of Requests for Admission to Plaintiffs, (2) Defendant's Fourth Set of Interrogatories to Plaintiffs, and (3) Defendant's Fifth Set of Requests for Production of Documents and Things to Plaintiffs filed by Avadel CNS Pharmaceuticals LLC.(Silver, Daniel)
Jan 18, 2022 37 Notice of Service (3)
Docket Text: NOTICE OF SERVICE of Defendant's Initial Invalidity Contentions filed by Avadel CNS Pharmaceuticals LLC.(Joyce, Alexandra)
Jan 7, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED re (77 in 1:21-cv-00691-MN, 23 in 1:21-cv-01594-MN, 36 in 1:21-cv-01138-MN) MOTION for Pro Hac Vice Appearance of Attorney Yi Ning filed by Avadel CNS Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC. ORDERED by Judge Maryellen Noreika on 1/7/2022. (dlw)
Jan 7, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Yi Ning for Avadel CNS Pharmaceuticals LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (Associated Cases: 1:21-cv-00691-MN, 1:21-cv-01138-MN, 1:21-cv-01594-MN)(srs)
Jan 6, 2022 36 Motion for Leave to Appear Pro Hac Vice (4)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Yi Ning - filed by Avadel CNS Pharmaceuticals LLC, Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra)
Jan 5, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: If, during the pendency of this case, Plaintiff(s) and Defendant(s) jointly wish to schedule a form of alternative dispute resolution ("ADR"), such as mediation, with Judge Hall, they should contact chambers by e-mail at Cailah_Garfinkel@ded.uscourts.gov or by phone. Additionally, if either side wishes to speak ex parte with Judge Hall regarding ADR matters, they may contact chambers via e-mail or by phone to arrange a time for a call. In addition, Judge Hall may in the future enter a sua sponte order setting an ADR teleconference. ORDERED by Judge Jennifer L. Hall on 1/5/2022. (ceg)
Jan 4, 2022 N/A Case Referred to Mediation (0)
Docket Text: CASE REFERRED to Magistrate Judge Jennifer L. Hall for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (Taylor, Daniel)
Jan 4, 2022 N/A Order Referring Case to Mediation (0)
Docket Text: ORAL ORDER REFERRING CASE to Mediation - IT IS HEREBY ORDERED that this matter is referred to a magistrate judge to explore the possibility of alternative dispute resolution. ORDERED by Judge Maryellen Noreika on 1/4/2022. (dlw)
Jan 4, 2022 32 SO ORDERED (4)
Docket Text: SO ORDERED re (30 in 1:21-cv-01138-MN, 17 in 1:21-cv-01594-MN, 73 in 1:21-cv-00691-MN) Stipulation and Order Regarding the Protective Order. Signed by Judge Maryellen Noreika on 1/4/2022. (dlw)
Jan 4, 2022 33 Stipulation (5)
Docket Text: STIPULATION and [Proposed] Order of Dismissal of Complaint as to Certain Defendants and to Amend Case Caption by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals PLC, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra)
Jan 4, 2022 34 SO ORDERED (5)
Docket Text: SO ORDERED re (20 in 1:21-cv-01594-MN, 33 in 1:21-cv-01138-MN, 75 in 1:21-cv-00691-MN) Stipulation and Order of Dismissal of Complaint as to Certain Defendants and to Amend Case Captions. Party Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals PLC, Avadel Specialty Pharmaceuticals, LLC, and Avadel US Holdings, Inc. terminated. Attorney Daralyn J. Durie; Alex M. Grabowski; Alexandra M. Joyce; Katherine E. McNutt; Sarah Propst; Evangeline Shih; Daniel M. Silver; Sarah W. Wang; Herman H. Yue; Marc N. Zubick; Bornali R. Borah and Kira A. Davis terminated as to these defendants only. Signed by Judge Maryellen Noreika on 1/4/2022. (dlw)
Dec 30, 2021 30 Stipulation (4)
Docket Text: STIPULATION and [Proposed] Order Regarding Protective Order by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals PLC, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel CNS Pharmaceuticals, LLC. (Joyce, Alexandra)
Dec 21, 2021 28 Stipulation (3)
Docket Text: STIPULATION and [Proposed] Order Regarding Revised Proposed Schedule - by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Dec 21, 2021 29 SO ORDERED (3)
Docket Text: SO ORDERED re (28 in 1:21-cv-01138-MN, 15 in 1:21-cv-01594-MN, 71 in 1:21-cv-00691-MN) Stipulation and Proposed Order Amending Scheduling Order - Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 10/21/2022. Opening Expert Reports due by 12/16/2022. Rebuttal Expert Reports due by 2/17/2023. Reply Expert Reports due by 4/14/2023. Expert Discovery due by 6/30/2023. Daubert Motions due by 7/7/2023. Claim Construction Opening Brief served by 5/27/2022. Claim Construction Answering Brief served by 6/17/2022. Claim Construction Reply Brief served by 7/8/2022. Claim Construction Surreply Brief served by 7/22/2022. Joint Claim Construction Brief filed by 7/29/2022. A Markman Hearing is set for 8/31/2022 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 10/23/2023 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 10/30/2023 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 12/21/2021. (dlw) Modified on 12/22/2021 (dlw).
Dec 17, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re (27 in 1:21-cv-01138-MN, 14 in 1:21-cv-01594-MN, 70 in 1:21-cv-00691-MN) STIPULATION TO EXTEND TIME for parties to meet and confer and submit a revised proposed scheduling order consistent with the Court's November 29, 2021 Oral Order to December 21, 2021. ORDERED by Judge Maryellen Noreika on 12/17/2021. (dlw)
Dec 17, 2021 27 Stipulation to EXTEND Time (4)
Docket Text: STIPULATION TO EXTEND TIME for parties to meet and confer and submit a revised proposed scheduling order consistent with the Court's November 29, 2021 Oral Order to December 21, 2021 - filed by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals PLC, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel)
Dec 10, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Sarah Propst for Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, and Avadel US Holdings, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Dec 10, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (69 in 1:21-cv-00691-MN, 13 in 1:21-cv-01594-MN, 26 in 1:21-cv-01138-MN) STIPULATION TO EXTEND TIME for the parties to meet and confer and submit a revised proposed scheduling order consistent with the Court's November 29, 2021 Oral Order to December 17, 2021 filed by Avadel CNS Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel Pharmaceuticals PLC, Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation. ORDERED by Judge Maryellen Noreika on 12/10/2021. Associated Cases: 1:21-cv-00691-MN, 1:21-cv-01138-MN, 1:21-cv-01594-MN(mdb)
Dec 10, 2021 26 Stipulation to EXTEND Time (4)
Docket Text: STIPULATION TO EXTEND TIME for the parties to meet and confer and submit a revised proposed scheduling order consistent with the Court's November 29, 2021 Oral Order to December 17, 2021 - filed by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals PLC, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel CNS Pharmaceuticals, LLC. (Silver, Daniel)
Dec 9, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [25] MOTION for Pro Hac Vice Appearance of Attorney Sarah Propst filed by Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel CNS Pharmaceuticals LLC, Avadel Pharmaceuticals plc, Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC. ORDERED by Judge Maryellen Noreika on 12/9/2021. (dlw)
Dec 9, 2021 25 Motion for Leave to Appear Pro Hac Vice (3)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sarah Propst - filed by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc.. (Joyce, Alexandra)
Dec 7, 2021 24 Notice of Service (5)
Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Chart filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Dec 6, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re (23 in 1:21-cv-01138-MN, 7 in 1:21-cv-01594-MN, 66 in 1:21-cv-00691-MN) STIPULATION TO EXTEND TIME for the parties to meet and confer and submit a revised proposed schedule consistent with the Court's November 29, 2021 Oral Order to December 10, 2021. ORDERED by Judge Maryellen Noreika on 12/6/2021. (dlw)
Dec 6, 2021 23 Stipulation to EXTEND Time (3)
Docket Text: STIPULATION TO EXTEND TIME for the parties to meet and confer and submit a revised proposed schedule consistent with the Court's November 29, 2021 Oral Order to December 10, 2021 - filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (Tigan, Jeremy)
Nov 29, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER re (60 in 1:21-cv-00691-MN, 19 in 1:21-cv-01138-MN) Letter - IT IS HEREBY ORDERED that these three actions (21-691, 21-1138, & 21-1594) will proceed on the same schedule with the pretrial conference and trial dates of October 23, 2023 and October 30, 2023 remaining in place. IT IS FURTHER ORDERED that the parties shall serve their final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) at least three weeks before Plaintiff serves its opening claim construction brief. The parties are encouraged to exchange proposed claim terms and proposed constructions early in the case and certainly prior to the deadline for final contentions. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. IT IS FINALLY ORDERED that, on or before 12/6/2021, the parties shall meet and confer and submit a revised proposed schedule consistent with this guidance. ORDERED by Judge Maryellen Noreika on 11/29/2021. (dlw)
Nov 11, 2021 21 Redacted Document (Main Document) (3)
Docket Text: REDACTED VERSION of (60 in 1:21-cv-00691-MN, 19 in 1:21-cv-01138-MN) Letter by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Attachments: # (1) Exhibit A)(Tigan, Jeremy)
Nov 11, 2021 21 Redacted Document (Exhibit A) (3)
Docket Text: REDACTED VERSION of (60 in 1:21-cv-00691-MN, 19 in 1:21-cv-01138-MN) Letter by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Attachments: # (1) Exhibit A)(Tigan, Jeremy)
Nov 8, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re (20 in 1:21-cv-01138-MN, 61 in 1:21-cv-00691-MN) STIPULATION TO EXTEND TIME for the parties to file a redacted version of their October 29, 2021 joint letter to November 11, 2021. ORDERED by Judge Maryellen Noreika on 11/8/2021. (dlw)
Nov 5, 2021 20 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME for the parties to file a redacted version of their October 29, 2021 joint letter to November 11, 2021 - filed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Tigan, Jeremy)
Oct 22, 2021 N/A Oral Order (0)
Docket Text: ORAL ORDER - As these matters involve the same parties and are related, the Court believes that they should proceed on the same schedule. THEREFORE, IT IS HEREBY ORDERED that the parties shall meet and confer to determine whether any changes to the current schedule in C.A. No. 21-691 need to be made in order to get the two cases on the same schedule and, on or before 10/29/2021, shall report back to the Court in a joint letter about any changes required. ORDERED by Judge Maryellen Noreika on 10/22/2021. (dlw)
Sep 30, 2021 17 Answer to Counterclaim (22)
Docket Text: ANSWER to [12] Answer to Complaint,, Counterclaim, by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc..(Tigan, Jeremy)
Sep 28, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Herman H. Yue and Marc N. Zubick for Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, and Avadel US Holdings, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Sep 27, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [16] MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Alex Grabowski, Sarah W. Wang, Bornali Rashmi Borah, and Herman Yue filed by Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel CNS Pharmaceuticals LLC, Avadel Pharmaceuticals plc, Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC. ORDERED by Judge Maryellen Noreika on 9/27/2021. (dlw)
Sep 27, 2021 16 Motion for Leave to Appear Pro Hac Vice (9)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Alex Grabowski, Sarah W. Wang, Bornali Rashmi Borah, and Herman Yue - filed by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc.. (Silver, Daniel)
Sep 15, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Daralyn J. Durie,Katherine E. McNutt, and Kira A. Davis for Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, and Avadel US Holdings, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Sep 14, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED re [15] MOTION for Pro Hac Vice Appearance of Attorney Daralyn Durie, Kira Davis and Katherine E. McNutt filed by Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc., Avadel CNS Pharmaceuticals LLC, Avadel Pharmaceuticals plc, Avadel Management Corporation, Avadel Legacy Pharmaceuticals, LLC. ORDERED by Judge Maryellen Noreika on 9/14/2021. (dlw)
Sep 14, 2021 15 Motion for Leave to Appear Pro Hac Vice (6)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daralyn Durie, Kira Davis and Katherine E. McNutt - filed by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc.. (Silver, Daniel)
Sep 13, 2021 14 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by Alexandra M. Joyce on behalf of Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc. (Joyce, Alexandra)
Sep 9, 2021 12 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. by Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel CNS Pharmaceuticals LLC, Avadel US Holdings, Inc., Avadel Legacy Pharmaceuticals, LLC.(Silver, Daniel)
Sep 9, 2021 13 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc.. (Silver, Daniel)
Aug 20, 2021 6 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. Avadel CNS Pharmaceuticals LLC served on 8/19/2021, answer due 9/9/2021. (Tigan, Jeremy)
Aug 20, 2021 7 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. Avadel Legacy Pharmaceuticals, LLC served on 8/19/2021, answer due 9/9/2021. (Tigan, Jeremy)
Aug 20, 2021 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. Avadel Management Corporation served on 8/19/2021, answer due 9/9/2021. (Tigan, Jeremy)
Aug 20, 2021 9 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. Avadel Pharmaceuticals plc served on 8/19/2021, answer due 9/9/2021. (Tigan, Jeremy)
Aug 20, 2021 10 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. Avadel Specialty Pharmaceuticals, LLC served on 8/19/2021, answer due 9/9/2021. (Tigan, Jeremy)
Aug 20, 2021 11 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. Avadel US Holdings, Inc. served on 8/19/2021, answer due 9/9/2021. (Tigan, Jeremy)
Aug 11, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
Aug 5, 2021 5 Summons Issued (Main Document) (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Avadel CNS Pharmaceuticals LLC on 8/5/2021; Avadel Legacy Pharmaceuticals, LLC on 8/5/2021; Avadel Management Corporation on 8/5/2021; Avadel Pharmaceuticals plc on 8/5/2021; Avadel Specialty Pharmaceuticals, LLC on 8/5/2021; Avadel US Holdings, Inc. on 8/5/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued, # (5) Summons Issued)(mal)
Aug 5, 2021 5 Summons Issued (Summons Issued) (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Avadel CNS Pharmaceuticals LLC on 8/5/2021; Avadel Legacy Pharmaceuticals, LLC on 8/5/2021; Avadel Management Corporation on 8/5/2021; Avadel Pharmaceuticals plc on 8/5/2021; Avadel Specialty Pharmaceuticals, LLC on 8/5/2021; Avadel US Holdings, Inc. on 8/5/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued, # (5) Summons Issued)(mal)
Aug 5, 2021 5 Summons Issued (Summons Issued) (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Avadel CNS Pharmaceuticals LLC on 8/5/2021; Avadel Legacy Pharmaceuticals, LLC on 8/5/2021; Avadel Management Corporation on 8/5/2021; Avadel Pharmaceuticals plc on 8/5/2021; Avadel Specialty Pharmaceuticals, LLC on 8/5/2021; Avadel US Holdings, Inc. on 8/5/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued, # (5) Summons Issued)(mal)
Aug 5, 2021 5 Summons Issued (Summons Issued) (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Avadel CNS Pharmaceuticals LLC on 8/5/2021; Avadel Legacy Pharmaceuticals, LLC on 8/5/2021; Avadel Management Corporation on 8/5/2021; Avadel Pharmaceuticals plc on 8/5/2021; Avadel Specialty Pharmaceuticals, LLC on 8/5/2021; Avadel US Holdings, Inc. on 8/5/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued, # (5) Summons Issued)(mal)
Aug 5, 2021 5 Summons Issued (Summons Issued) (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Avadel CNS Pharmaceuticals LLC on 8/5/2021; Avadel Legacy Pharmaceuticals, LLC on 8/5/2021; Avadel Management Corporation on 8/5/2021; Avadel Pharmaceuticals plc on 8/5/2021; Avadel Specialty Pharmaceuticals, LLC on 8/5/2021; Avadel US Holdings, Inc. on 8/5/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued, # (5) Summons Issued)(mal)
Aug 5, 2021 5 Summons Issued (Summons Issued) (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Avadel CNS Pharmaceuticals LLC on 8/5/2021; Avadel Legacy Pharmaceuticals, LLC on 8/5/2021; Avadel Management Corporation on 8/5/2021; Avadel Pharmaceuticals plc on 8/5/2021; Avadel Specialty Pharmaceuticals, LLC on 8/5/2021; Avadel US Holdings, Inc. on 8/5/2021. (Attachments: # (1) Summons Issued, # (2) Summons Issued, # (3) Summons Issued, # (4) Summons Issued, # (5) Summons Issued)(mal)
Aug 4, 2021 1 Complaint* (1)
Aug 4, 2021 1 Complaint (Main Document) (15)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3672835.) - filed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(mal)
Aug 4, 2021 1 Complaint (Exhibit A-F) (30)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3672835.) - filed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(mal)
Aug 4, 2021 1 Complaint (Civil Cover Sheet) (1)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Avadel CNS Pharmaceuticals LLC, Avadel Legacy Pharmaceuticals, LLC, Avadel Management Corporation, Avadel Pharmaceuticals plc, Avadel Specialty Pharmaceuticals, LLC, Avadel US Holdings, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3672835.) - filed by Jazz Pharmaceuticals, Inc., Jazz Pharmaceuticals Ireland Limited. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(mal)
Aug 4, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal)
Aug 4, 2021 3 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,077,079,B1. (mal)
Aug 4, 2021 4 Disclosure Statement (1)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Jazz Pharmaceuticals plc for Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc. filed by Jazz Pharmaceuticals Ireland Limited, Jazz Pharmaceuticals, Inc.. (mal)
Menu